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ABSTRACT 
 
William M. Gilliland, Jr.: Development and Applications of a Microchip Capillary 
Electrophoresis-High Pressure Mass Spectrometry Platform 
(Under the direction of J. Michael Ramsey) 
 
This work describes the pairing of electrospray ionization (ESI) with high pressure mass 
spectrometry (HPMS) with the goal of developing a miniature analytical platform as an 
alternative to traditional liquid chromatography-MS (LC-MS) systems. LC-MS systems are the 
standard for many chemical analyses and are used for a wide range of applications, but their size 
and complexity limits them to centralized labs. Microchip capillary electrophoresis (CE) coupled 
with HPMS presents an opportunity to provide an inexpensive, simple, and targeted separations-
MS system. The work here demonstrates the initial steps for coupling ESI and HPMS, 
improvements for the analysis of small molecules, and strategies and applications for ESI-HPMS 
of intact proteins.  
The first step for ESI-HPMS was designing an interface to conduct ions from 
atmospheric pressure into the ion trap at ~1 Torr. The initial interface consisted of a capillary 
inlet and a simple DC “gate” lens. With this interface, the twenty common amino acids were 
detected when infused. Small peptides were detected with much greater sensitivity than amino 
acids for this interface, and microchip CE-HPMS of peptide standards was demonstrated. In 
addition, tandem mass spectrometry under HPMS conditions was performed with clusters of 
small molecules as well as with a small peptide (RGES). 
After initial development and proof-of-concept demonstration, several improvements 
were made with ESI-HPMS. An aperture was used in place of a capillary, and a tube lens was 
 iv 
found to be more effective for small molecules than the “gate” lens. The RF drive frequency was 
increased to 30 MHz to improve resolution, and the trap size was decreased to critical 
dimensions of about 100 µm to maintain mass range. A SLIT trap was used to increase ion 
storage capacity. With these improvements, the twenty common amino acids were infused and 
detected with a 28-fold improvement in S/N and a 2.6-fold improvement in peak width over the 
previous HPMS analysis. Microchip CE-HPMS was then used for two applications: the analysis 
of amino acids in cell growth medium and the detection of opiates in urine.  
Finally, CE-HPMS was used for the analysis of intact proteins. A printed circuit board 
ion funnel was designed and implemented. The small proteins cytochrome c (12.3 kDa) and 
myoglobin (17 kDa) were detected. The mass range was adjusted to detect large proteins BSA 
(66 kDa) and an IgG2 (~150 kDa). CE-HPMS was then used for the detection of glycated 
hemoglobin in whole blood lysate. HPMS calculations of hemoglobin glycation in clinical 
samples were then correlated (R2 = 0.75) with HbA1c detection by immunoassay.  
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“Piglet noticed that even though he had a very small heart, it could hold a rather large 
amount of gratitude” – A.A. Milne 
To my family 
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 Chapter 1: Introduction 
1.1 Background and Motivation 
Mass spectrometry (MS) is a powerful analytical technique due to its sensitivity, 
versatility, and ability to provide chemical and structural information of molecules and has long 
been the ‘gold standard’ for many types of chemical analyses. However, most MS systems are 
limited to centralized or academic laboratories because of their complexity and their size, weight, 
and power (SWaP) requirements. Because of the ability of MS to rapidly and reliably detect and 
identify molecules, there are many applications that would benefit from having an MS on-site. 
To that end, many research groups have developed miniature mass spectrometers for 
environmental monitoring,1–3 explosives4 and chemical warfare agent detection,5,6 forensics,7,8 
and clinical analyses.9 The primary limitation to the miniaturization/portability of these systems 
is the strenuous vacuum requirements to operate the mass analyzer at pressures much below 
atmosphere (<1 mTorr). 
 Since before the 2000’s, the Ramsey group has been working to develop miniature mass 
spectrometers based on a technique called high pressure mass spectrometry (HPMS). Operation 
of the components of the mass spectrometer at high pressures (>1 Torr) greatly reduces the 
vacuum requirements such that turbomolecular pumps are no longer required, and the mass 
spectrometer can be operated using only mechanical pumps. While turbo pumps can produce low 
pressures necessary for most MS analysis, they are bulky, high-power, and expensive, which are 
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all undesirable qualities for a miniature mass spectrometer. Thus, moving to higher operational 
pressures and using mechanical pumps facilitates miniaturization. 
  The centerpiece of HPMS is the miniature ion trap mass analyzer. The use of miniature 
ion traps maintains practical voltage and power requirements for the high radio frequency (RF) 
drive signal required for HPMS. The development of mini-CITs and HPMS has led to a 
commercially available hand-held mass spectrometer from 908 Devices, Inc., primarily 
developed for threat detection of various gaseous and volatile analytes.  
While previous HPMS work has used an electron ionization (EI) source, the use of 
electrospray ionization (ESI) expands the range of analytes to include biomolecules and other 
liquid-borne analytes.10 In addition to broadening the number and type of analytes available for 
characterization by MS, ESI provides a method for coupling liquid-phase separations to MS 
systems. These separation steps prior to mass analysis can greatly aid in the identification and 
characterization of compounds and are necessary for the analysis of complex mixtures. As there 
is some loss in mass spectral resolution under HPMS conditions, a separation step prior to the 
MS is a method for recapturing some of the selectivity incurred by this loss. Currently, liquid 
chromatography separations coupled to MS (LC-MS) are the standard for many chemical 
analyses, but LC systems require large pumps and complex sets of valves and tubing, neither of 
which are amenable to a miniature analytical platform.  
A smaller and simpler alternative to LC is microchip capillary electrophoresis. Microchip 
capillary electrophoresis (CE) was pioneered in the Ramsey lab separately but simultaneously to 
the development of miniature mass spectrometry. Initial research focused on fluorescence 
detection but these CE devices were eventually interfaced to commercial mass spectrometers via 
ESI. Since then, CE-MS research in the Ramsey lab has focused primarily on strategies for the 
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separation and detection of biomolecules, including surface chemistries for the microfluidic 
devices. Microfluidic CE-MS has been demonstrated for many biological and biochemical 
applications from the analysis of small molecules to intact antibodies. While the usefulness of 
microfluidic CE-ESI devices coupled with commercial mass spectrometers is proven, the small 
footprint, simplicity, and wide range of applications for these devices also make them excellent 
candidates for pairing with a miniature mass spectrometer.  
The marriage of microfluidic CE and HPMS presents an opportunity for a fully miniature 
analysis platform for biomolecule analysis, which could provide a simple and inexpensive 
alternative to conventional LC-MS systems. The following sections detail the principles and 
strategies underlying HPMS and microfluidic CE, as well as considerations for an ESI interface 
to HPMS and its combination with microfluidic CE into a single analytical platform.  
 
1.2 High Pressure Mass Spectrometry 
1.2.1 Miniature Mass Analyzers 
The miniaturization of the mass analyzer is central to the reduction in the overall size of 
the mass spectrometer. Nearly all types of common mass analyzers have been reduced in size to 
varying extents, including time-of-flight (TOF),11,12 sector-type analyzers,13,14 linear 
quadrupoles,15,16 and many variations on quadrupolar ion traps.17–20 Ion traps have been at the 
center of most miniaturization efforts for several reasons. First, their performance scales 
favorably with decreasing size as the dimensions of an ion trap do not fundamentally affect the 
mass resolution. Second, ion traps can be produced with simplified geometries, easing 
fabrication at reduced scales. CITs18,21–23 and rectilinear ion traps (RITs)19 consist of exclusively 
planar electrodes, giving them simple geometries compared with their hyperbolic counterparts, 
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but still produce useful MS data.24,25 Third, ion traps have the ability to perform tandem mass 
spectrometry (MS/MS) with a single analyzer, which reduces the overall footprint of the 
instrument, reduces chemical noise, and increases the selectivity of the instrument. Finally, ion 
traps have significantly higher operating pressures than other mass analyzers (~1 mTorr 
compared to 10-4 Torr or lower). Operation at higher pressures is important for reducing the 
vacuum requirements in a miniature instrument. Because of their favorable scaling, simple 
geometry, and ability to perform MS/MS, ion traps were chosen as the mass analyzer for our 
miniaturization efforts.  
1.2.2 Quadrupole Ion Traps (QITs) 
The quadrupole ion trap was first introduced by Paul and Steinwedel in the 1950s26 and 
became commercially available as a mass analyzer and detector for gas chromatography in 1983 
from Finnigan, Corp.27 A picture and a schematic of a QIT are shown in Figure 1.1 with the 
trap’s size defined by the r0 and z0 dimensions labeled in Figure 1.1b. The r0 parameter is the 
radius of the ring electrode, and z0 is half the distance of the space between endcaps.  The field in 
the trap is produced by voltages applied to the three electrodes, a ring and two endcaps. Ions 
enter and exit the trap via holes in each of the endcap electrodes. The hyperbolic shape of the 
electrodes produces a field that is largely quadrupolar. 
In the QIT’s normal mode of operation, an RF potential is applied to the ring electrode, 
and the endcaps are grounded. Ion motion in the quadrupolar field created by the voltages 
applied can be described by the second order differential Mathieu equation. A solution to the 
Mathieu equation in the axial (z) and radial (r) dimensions gives az, qz, ar, and qr, known as 
trapping parameters:28 
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 az=		 - 16eUm(r02+ 2z02)W2 1.1 
 
 qz= 
8eV
m(r02+ 2z0
2)W2
 1.2 
 
 𝑎#= 8eUm(r02+ 2z02)W2 1.3 
 
 𝑞#=  - 4eVm(r02+ 2z02)W2 1.4 
 
where U is a DC potential applied to the ring electrode, e is the elementary charge of the ion, m 
is the mass of the ion, r0 is the radius of the ring electrode, 2z0 is the endcap spacing, V is the 
drive RF voltage (0-p) amplitude applied to the ring electrode, and W is the angular RF 
frequency applied to the ring (2pf). Because the trapping parameters in each dimension are 
related to each other by a factor of two and opposite in sign, regions of radial (upward pointing) 
and axial stability (downward pointing) can be plotted in qz and az space (Figure 1.2). Areas 
where the regions overlap are points at which ions can be stably trapped and are known as 
stability regions. Region A is of particular interest for use of the QIT as a mass analyzer, and a 
close-up of Region A from Figure 1.2 is shown in Figure 1.3. 
 When operated as a mass analyzer, ion traps are often operated without a DC potential on 
the ring, and therefore az = 0. Under these conditions, trapped ions lie along the qz axis, with 
lower m/z ions having higher values of q for a given RF voltage and frequency, as shown in 
Equation 1.2. Ions can be ejected from the trap in order of increasing mass by ramping the 
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amplitude of the RF voltage, scanning the ions along the qz axis until they reach the boundary of 
the stability region at qz = 0.908 (shown in Figure 1.3). At qz > 0.908, ions no longer have a 
stable trajectory in the axial dimension and are ejected through holes in the endcap electrodes. 
This type of scan is known as a mass-selective instability scan. The time and voltage at the point 
of ejection can be used to determine an ion’s m/z. 
1.2.3 Considerations for High Pressure Operation 
As the pressure of the mass analyzer is increased to facilitate miniaturization, it is 
important to take into account the effects of pressure on MS performance. Two important 
measures for a mass spectrometer’s analytical performance are its resolving power and its mass 
range. Resolving power for QIT, assuming slow scan conditions, can be expressed as:29 
 
 m
∆m
∝ 
Ωτ
4 3
 1.5 
 
where m is the ion mass, Dm is the width of the mass spectral peak, W is the applied angular RF 
frequency, and t is the collisional relaxation time, which is inversely proportional to the pressure 
(P) of the buffer gas. As a result, the resolving power can be expressed proportionally: 
 
 m
∆m
∝	Ω
P
 1.6 
  
Thus, in order to maintain resolving power, the operational frequency must be increased 
proportionally with the increased pressure. Increases in frequency improve the resolving power 
but result in a decreased mass range if all other parameters remain constant. The mass range can 
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be considered using the maximum mass that can be ejected from a trap (rearranged from 
Equation 1.2): 
 
 (
m
z
)
max
= 
8Vmax
qmaxW
2(r02+2z02)
 1.7 
 
where z is the charge, m is the ion mass, Vmax is the maximum amplitude of the RF voltage, qmax 
is the trapping parameter and constant (usually 0.908), and r0 and z0 are the dimensional 
parameters of the trap. To make up for the loss of mass range at increased frequencies, the drive 
RF voltage can be increased or the dimensions of the trap can be decreased. There are, however, 
practical limits to increasing the voltage, both due to the overall power constraints of a miniature 
mass spectrometer and the possibility of electrical breakdown (arcing). Thus, decreasing the trap 
size is necessary in order to increase the frequency and maintain practical voltages. For 
comparison, typical QITs have r0 of 1 cm and operate with a frequency around 1 MHz.  
Therefore, an increase in frequency to 10 MHz would require a decrease in the size of the trap to 
an r0 of about 1 mm to maintain similar operating voltage. 
1.2.4 Miniature Cylindrical Ion Traps (CITs)  
Cylindrical ion traps produce similar trapping fields to QITs but with a simplified 
geometry. CITs consist of two planar endcaps and a cylindrical ring electrode, and this simple 
geometry makes them much more amenable to miniaturization than QITs. While ion trap 
operation remains the same for CITs (RF applied to the ring electrode), the electric field 
produced is slightly different than that of QITs. For QITs, the electrodes are hyperbolic and the 
trapping field is largely quadrupolar, but some deviations from a purely quadrupolar field exist 
due to truncation of electrodes to a finite size, endcap apertures, machining imperfections, and 
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often an intentional axial stretch to a non-ideal geometry. The trapping field in CITs is largely 
similar to QITs but has more significant components of higher than quadrupolar order (due to 
geometry simplifications), especially near the edges of the trap. To illustrate this point, simulated 
equipotential lines for a QIT and CIT are shown in Figure 1.4.30 Near the center of the trap, the 
field in a CIT closely resembles that of a QIT, where higher order fields are weakest, and where 
ions are typically found when trapped. At the edges of the CIT, deviation from quadrupolar 
character are expected and higher order fields are strongest. These higher order fields can 
contribute to a reduction in stability at higher qz values. 
Although they result in instability at higher qz, higher order multipole fields can be used for 
what is known as double resonance ejection.31 A small axial RF voltage (with frequency w) may 
be applied to one or both endcaps to take advantage of these multipole fields. When the secular 
frequency (or a harmonic) of the ions is doubly resonant with the frequency of the axial RF 
signal and the frequency of nonlinear resonances in the trap, ions can be ejected from the trap. 
The resonances occur at specific fractions of the drive RF frequency, most notably at w = W/3 
and 2W/3 (hexapolar), and W/4 (octopolar). The application of an axial RF voltage for resonant 
ejection expands the mass range by reducing the ejection qz and voltage necessary for ejection 
and has been shown to improve both the resolution and signal intensity of the mass analyzer.  
 CITs at traditional QIT dimensions (r0 » 1 cm) have been researched since the 
1970s,22,32,33 and miniaturization efforts began at least as early as 1991, with a CIT of 
r0 = 2.5 mm used as a mass analyzer.24 Since then, the use of miniature CITs for mass 
spectrometry applications was pioneered primarily by groups at Purdue17 and Oak Ridge 
National Laboratory.18,34 MS miniaturization efforts at Purdue moved primarily to rectilinear ion 
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traps in the early 2000s.19,35 At Oak Ridge, miniature ion traps were developed with sub-mm 
dimensions,18,34,36 with ion traps as small as r0 = 20 µm fabricated and operated.37 
1.2.5 Previous Work in High Pressure Mass Spectrometry 
Operation of an ion trap mass spectrometer at higher than traditional pressures 
(>1 mTorr) would facilitate miniaturization by reducing the pumping requirements to reach the 
desired pressure. Cooks and Ouyang demonstrated that a rectilinear ion trap could be operated at 
pressures up to 50 mTorr with helium as the buffer gas38 and theoretically characterized mass 
spectral performance at pressures up to 250 mTorr.39 Other work from Cooks and Ouyang has 
shown that ions can be trapped at high pressure (~1 Torr), but mass analysis was still performed 
at low pressures (<10 mTorr) using a discontinuous atmospheric pressure interface (DAPI).40  
The work described here aims to operate CITs at pressures near 1 Torr, where 
turbomolecular pumps are no longer needed. As discussed in Section 1.2.3 and described 
theoretically,41 the frequency applied to the ion trap must be increased at higher pressures in 
order to maintain reasonable mass resolution, with a corresponding decrease in trap size to 
maintain practical voltages. Before operation at high pressure, the first steps in high frequency 
operation of miniature ion traps were initially demonstrated at traditional buffer gas pressures 
(~1 mTorr), to ensure that CITs could function as mass analyzers with higher frequencies. 
Miniature cylindrical ion traps with radii between 0.5 and 2.5 mm were tested at low pressures 
(~1 mTorr) by several research groups at frequencies from 1.6 to about 8 MHz.17,31,34,36,42,43 
While miniaturization efforts have continued, mass analysis at pressures greater than 50 mTorr 
remains relatively unexplored. 
The first mass analysis with both high pressure and high frequency using a microscale 
CIT has recently been demonstrated by Blakeman, et al.44 The pressure was 1 Torr with helium 
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as the buffer gas, and the CIT had r0 of 500 µm and was operated at up to 9.5 MHz. A filament 
or yttria coated disc was used as an electron ionization (EI) source. Spectra of 2-chloroethyl ethyl 
sulfide, a common chemical warfare agent simulant for mustard gas, at three pressures are shown 
in Figure 1.5. As the helium buffer gas pressure was increased from 0.062 to 1.21 Torr, the peaks 
broaden slightly, but the primary peaks in the spectrum remain visible at m/z 124 (molecular 
ion), 89 (loss of chlorine), and 75 (loss of methyl chloride). 
While the demonstration of HPMS in helium is a good step toward miniaturization, 
operation of HPMS with ambient air as the buffer gas would eliminate the need for an external 
gas source and further reduce the final size of the instrument. HPMS was demonstrated with 
another r0 = 500 µm CIT with a glow discharge ionization source in nitrogen and air buffer 
gases.45 Figure 1.6 shows mass spectra of p-xylene in helium, nitrogen and air buffer gases. The 
peaks in nitrogen and air were significantly broader than those in helium. Isotopic features were 
not visible in nitrogen and air, but three major features of p-xylene were observable around 
m/z 106, 91, and 77, demonstrating that useful molecular information could still be obtained 
using HPMS with air as a buffer gas.  
The next steps for HPMS development, as suggested in Equations 1.6 and 1.7, is to 
increase the drive frequency to improve mass resolution and decrease the size of the ion trap to 
minimize RF voltage requirements. At 1 Torr of ambient air buffer gas, Blakeman showed that 
peak widths of p-xylene could be improved from 5.5 to 0.8 m/z with increased drive frequency 
and appropriate scaling of the trap.46 The frequency was operated from 6.14 up to 59.44 MHz, 
and traps were scaled down from r0 = 500 µm to r0 = 100 µm. While ion traps as small as 
r0 = 20 µm have been fabricated37 and traps as small as r0 = 1 µm theoretically studied,47,48 the 
CIT with r0 of 100 µm is, at this point, the smallest used to perform mass spectrometry.  
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A major concern with the miniaturization of CITs is the loss of ion trapping capacity 
incurred at smaller dimensions, which in turn decreases the dynamic range of the mass analyzer. 
Dehmelt introduced an approximation for ion storage in a QIT:49 
 
 Nmax= 2.8 x	107 Dzz0 1.8 
 
where Nmax is the maximum number of ions that can be stored in the trap, z0 is the axial 
dimension of the trap, and Dz is the pseudopotential well depth in the z direction, at low values of 
qz given by: 
 
 
Dz= 
qzV
8
 1.9 
 
where qz is the Mathieu parameter introduced in Equation 1.2 and V is the 0-to-peak trapping 
voltage applied to the ring electrode. From Equation 1.8, the capacity of the trap decreases 
linearly with trap size. One way to make up for lost ion trapping capacity and increase dynamic 
range of miniature CITs is to operate an array of CITs in parallel.37,50,51 While arrays of CITs can 
increase the sensitivity, the primary drawback is the possibility of heterogeneity between each of 
the individual trapping elements, which could result in significant loss of mass resolution. 
 A recently developed alternative to arrays of CITs for improving the sensitivity of 
miniature ion traps is the stretched length ion trap, or SLIT, which stretches the CIT in the plane 
of the electrode.52,53 A schematic showing the differences in geometry between the CIT and 
SLIT is shown in Figure 1.7. The operation of the SLIT is fundamentally the same as a CIT, with 
RF applied to the ring electrode and two grounded endcaps, just with a larger ion storage 
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volume. SLITs have been successfully operated as mass analyzers, and, at low pressure, SLITs 
have been demonstrated to have an order of magnitude better sensitivity than CITs without loss 
of resolution. In the same work, SLITs were shown to operate at 1 Torr with nitrogen as the 
buffer gas. To further improve the sensitivity of the mass analyzer, arrays of SLITs or a 
serpentine geometry could be implemented.  
 In addition to improving the sensitivity of miniature ion traps, improving the selectivity, 
or the ability to distinguish similar chemical components, is also of interest, especially at high 
buffer gas pressures, where mass resolution degrades. Ion traps have the ability to perform 
tandem mass spectrometry, and it has recently been demonstrated that MS/MS can be performed 
with both microscale CITs and SLITs at pressures up to 1 Torr with air as the buffer gas.54 
Hampton’s work focused primarily on small organic analytes such as bromobenzene, 
trichlorbenzene, and N,N-dimethylaniline.  
 Thus far, all HPMS research with miniature ion traps has used an EI or glow discharge 
(GDEI) ion source. These sources produce ions using a high energy electron beam (EI) or plasma 
(GDEI), so the analytes must be in the gas phase prior to ionization and mass analysis. Thus, 
small volatile and gas phase analytes were the initial primary targets for HPMS analysis. 
However, HPMS could be applied to many more applications for the analysis of larger and/or 
nonvolatile molecules with changes in optimal operational parameters and a different ion source, 
such as ESI. In addition, coupling HPMS with ESI opens the possibility of including a liquid-
phase separation step such as CE to further expand the utility of the technique. 
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1.3 Microchip Capillary Electrophoresis and Electrospray Ionization 
The primary goal of this work is to optimize HPMS operation with ESI as the ion source, 
specifically microchip ESI devices. Because many of the applications for ESI-HPMS involve 
coupling HPMS with microchip capillary electrophoresis, a brief introduction to CE, microchip 
CE-ESI devices, and previous applications of microchip CE-ESI-MS is presented here.  
1.3.1 Capillary Electrophoresis 
Electrophoresis can be defined as the movement of electrically charged species in a 
conductive liquid medium under the influence of an electric field.55 Initial developments using 
electrophoresis as the separation mechanism needed a solid support such as paper or gels to 
prevent convectional distortion of analyte bands.56 While gel electrophoresis has been an 
extremely valuable asset to biological and biochemical research, its primary disadvantage is the 
speed of the separation, which is limited by Joule heating. In the early 1980s, Jorgenson and 
Lukacs showed that electrophoresis could be performed in free solution using narrow-bore, open 
tubular capillaries, termed capillary zone electrophoresis (CZE).57–59 The high surface area-to-
volume ratio gave these capillaries the ability to efficiently dissipate heat, and CZE separations 
could be performed with up to 30 kV applied at ambient temperature. 
The typical instrumental setup for CZE has remained relatively unchanged since its 
introduction. A basic instrumental schematic for CZE is shown in Figure 1.8.60 Two buffer 
reservoirs are in fluidic connection via a capillary, across which a potential is applied. The 
applied potential generates an electric field that drives the separation. After sample injection, 
analytes are separated based on their apparent mobility (µapp), which is the sum of both their 
electrophoretic mobility (µEP) and the electroosmotic mobility of the system (µEO): 
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 µapp=	µEP+	µEO 1.10 
 
The electrophoretic mobility of an analyte ion is dependent on the charge of the ion (q), 
the viscosity of the solution (h), and the hydrodynamic radius of the ion (rh):  
 
 µEP= 
q
6πη𝑟& 1.11 
 
Thus, CZE separates analytes based on their charge to size ratio and conformation in solution. A 
smaller, more highly charged particle will migrate faster than a larger, less charged particle.  
 The electroosmotic mobility of an analyte depends on the electroosmotic flow (EOF) 
produced in the capillary. EOF arises from the formation of an electrical double layer at the wall 
of the capillary. Briefly, the double layer consists of an immobile layer of counter ions of 
opposite charge to those fixed to the wall and a diffuse layer, containing a high concentration of 
mobile counter ions. When an electric field is generated across the capillary, the mobile counter 
ions will migrate, generating bulk fluid flow in the capillary via viscous drag. In an uncoated 
silica capillary, the surface silanol groups are usually negatively charged, so the double layer 
consists of an immobile layer of cations and a diffuse layer of cations. When a voltage is applied, 
the mobile cations in the diffuse layer will migrate toward the cathode. Thus, if the magnitude of 
the EOF is great enough, all species (anions, cations, and neutrals) will migrate in the same 
direction.  
1.3.2 Microchip Capillary Electrophoresis 
About a decade after the development of CZE, capillary electrophoresis was performed 
on glass or silicon microchips fabricated with micromachining techniques pioneered by the 
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semiconductor industry.61–67 Performing CE in planar microchannels (10-100 µm) with high 
aspect ratios (width to height) provided the same Joule heat dissipation advantages of small-bore 
capillaries.68,69 One of the primary advantages of microchip CE over traditional CZE is the 
ability to incorporate many steps of analysis on a single device, and for this reason, initial 
devices were termed µ-total analysis systems.69,70  
The devices used for this work are adapted from this initial work on microchips, with the 
primary difference being the monolithic integration of an ESI emitter onto the device. A typical 
device is shown in Figure 1.9.60 The channels are created in glass using photolithography and 
wet etching, and the fabrication process is described in detail in Appendix I. The device 
incorporates four important elements onto a single platform: an injection cross, the separation 
channel, the pumping channel, and the integrated ESI emitter.  
The injection cross provides a simple method for sample handling and injection prior to 
CE separation. This strategy has been used previously and is common for microfluidic 
architectures.62,65,68 Compared to conventional CZE, this method of sample introduction is 
simpler and faster, resulting in less band broadening. Normal methods of injection for CZE 
usually involve moving the sample or buffer reservoirs, which can be mechanically complicated 
and can result in diffusional broadening before voltage is applied for the separation. By contrast, 
sample handling on the microfluidic platform is performed without complex moving parts. 
Injections on the microchip are performed either electrokinetically or hydrodynamically, 
described in detail in Appendix II. For electrokinetically gated injections, appropriate voltages 
are applied to all reservoirs to gate the sample in reservoir 1 towards the waste reservoir (3) and 
then switched to balance reservoirs 2 and 3, injecting sample into the separation channel. After 
an appropriate plug has been injected, the voltages are switched to the initial conditions to 
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perform the separation. Electrokinetic injections are simple and very fast but can result in sample 
injection bias if analytes have significantly different electrophoretic mobilities. In contrast, 
hydrodynamic injections are slower but do not produce any sample introduction bias.  For 
hydrodynamic injections, all voltages are turned off and pressure is applied to reservoirs 2 
(sample) and 1 (buffer) resulting in sample being directed into the separation channel. After a 
short time, pressure is only applied to reservoir 1 to load the sample band completely into the 
separation channel. Voltages are then applied to reservoirs 1 and 4 and pressure removed from 
reservoir 2 and normal zone electrophoresis occurs.  
The separation channel pictured in Figure 1.9 is typically 23 cm in length with six turns 
to minimize the footprint of the device. The turns are asymmetrically tapered (see inset) in order 
to minimize geometric dispersion known as the “racetrack effect.”71–73 The racetrack effect refers 
to turns with uniform channel dimensions where analytes on the inside of the turn migrate 
significantly faster than analytes on the outside of the turn, resulting in a wider overall band. The 
effect can be reduced by increasing the turn radius or as done here reducing the width of the 
channel. The separation channel and pumping channel join just before terminating at the corner 
of the device, which acts as the integrated ESI emitter. 
Many research groups have worked to interface microchip platforms with ESI. Strategies 
for developing this interface include spraying from the flat surface of a microchip,74,75 inserting 
an electrospray emitter,68,76,77or monolithic integration of an emitter.78–80 Of these, monolithic 
integration of the emitter would be best to minimize band broadening and preserving ESI 
integrity, but many strategies for monolithic integration involve complex fabrication. A simple 
solution to this complex fabrication problem was a variation on spraying from a surface of the 
microchip introduced by Mellors, et al., where electrospray was performed from the corner of 
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the glass substrate.81 The sensitivity and stability of the ESI source using this strategy was found 
to be comparable to typical pulled capillary emitters with no detectable band broadening. Thus, 
the portion of the device involving the ESI emitter has remained relatively unchanged since its 
introduction in 2008. 
The final element of the microfluidic ESI device is the pumping channel, labeled in 
Figure 1.9. To perform ESI, bulk fluid flow and an emitter with an applied voltage are necessary. 
For these microchips, the pumping channel intersects the separation channel near the 
electrospray emitter and serves both of these purposes. The voltage applied at reservoir 4 
completes the circuit for performing CE and simultaneously provides the voltage necessary for 
ESI to occur. The pumping channel also provides the bulk fluid flow necessary for ESI, either 
via an applied head pressure or using an electroosmotic pumping strategy involving different 
surface coatings in the separation and pumping channels.74,81 
The architecture shown in Figure 1.9 has remained relatively unchanged since its initial 
development and has been used for many applications, providing high efficiency separations 
with the added benefit of MS detection. Efficient surface coatings82 have enabled the use of these 
microfluidic devices for many biological applications including 2D separations (LC-CE) of 
peptides and proteins,83 characterization of monoclonal antibodies and antibody drug 
conjugates,84,85 study of hemoglobin glycation for diabetes diagnostics,86 and hydrogen-
deuterium exchange to study protein structure.87 Because of their small platform, simple 
operation, and ability to perform high efficiency separations, these microfluidic CE-ESI devices 
are ideal candidates to pair with a miniature HPMS-based mass spectrometer. 
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1.4 Design Considerations for CE-ESI-HPMS 
Because all previous HPMS analysis has involved an EI or GDEI ion/ionization source, 
there are additional design considerations for ESI-HPMS analysis. First, ions must be efficiently 
transported from atmospheric pressure into the vacuum chamber containing the mass analyzer. 
Previously, ions were generated in the same chamber as the mass analyzer or already in the 
trapping volume. After transport into the chamber containing the mass analyzer, externally 
generated ions must be trapped, so the reduced pseudopotential well depth of miniature ion traps 
may be of concern. Finally, parameters for operation of the mass analyzer must be adjusted to 
accommodate significantly higher mass and higher m/z ions. Thus far, mass analysis has focused 
on small organic ions of less than about 150 m/z, and those ions are usually singly charged, 
meaning the masses are also usually less than 150 Da. One of the advantages of ESI is the ability 
to volatilize and ionize large species that are often multiply charged, so HPMS conditions will 
have to be optimized to accommodate analysis of these species. 
1.4.1 Ion Source and Ion Transport to the Mass Analyzer 
The sensitivity of an ESI-MS system is dependent upon the ionization efficiency of the 
source as well as the efficiency of ion transport to the mass analyzer, often through multiple 
vacuum stages.  A typical ESI-MS system has an emitter and an inlet capillary or orifice to 
conduct ions into the first vacuum stage. Improvements to the ESI source itself have largely 
focused on reducing the flow rate of the electrospray to improve sensitivity. Termed nano-ESI 
(nESI), the reduction in flow rate subsequently reduces the size of the droplets produced, and 
therefore fewer collisions and less evaporation is required for the desolvation of analyte ions.88–90 
Ionization efficiency for nESI approaches 100% in the low nL/min flow regime, but on-line 
separations typically operate at higher flow rates.91,92  
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Despite improvements in the ion source and ionization efficiency, the primary limitation 
of the sensitivity of ESI-MS systems is in the transport of ions to the mass analyzer. A significant 
portion of analyte ions are lost due to limited flow or collisions with surfaces at the inlet or other 
conductance limits in the instrument.93–95 Ion transmission efficiencies from ESI source to 
detector are reported in the 0.01 – 0.1% range.96–100 Strategies to improve sensitivity include 
using larger bore capillaries or apertures,101 multiple inlet capillaries and/or nESI sources,102,103 
different capillary or aperture geometries,104,105 performing nESI in the first vacuum stage of the 
mass spectrometer (sub-ambient ESI),95,106–108 and improved ion optics in each vacuum region of 
the mass spectrometer. Large ID capillaries and multiple ESI emitters improve sensitivity but 
significantly increase the pumping requirements of the mass spectrometer. Special capillary 
geometries can be difficult to fabricate, and performing ESI below atmospheric pressure 
becomes complex with a microchip as the ionization source. For these reasons, ESI-HPMS 
development has focused on the ion optics that transport ions throughout the mass spectrometer. 
Ion funnels are of particular interest as an ion transport strategy for HPMS. The ion 
funnel was first developed at Pacific Northwest National Laboratory in the late 1990’s by Dick 
Smith’s group as a way of transporting ions with near 100% efficiency through the first pumping 
stage (typically 0.1 to 30 Torr) of a mass spectrometer.109 Many improvements have been made 
to ion funnels since their development, but most of the overall features remain the same. Ion 
funnels consist of a stack of concentric, closely spaced ring electrodes decreasing in diameter to 
a conductance-limiting electrode, radially confining the ions’ trajectories. A pair of RF voltages 
180 degrees out of phase are applied to each adjacent electrode, and a DC gradient is usually 
applied along the axis of the funnel to propel ions towards the conductance limiting electrode. 
Because of their excellent ion transfer efficiency and high pressure operation range, ion funnels 
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are ideal candidates to use with ESI-HPMS. It is important to note that ion funnels, while 
extremely efficient for many large species, suffer from poor ion transmission of low m/z (<200) 
species. For small molecule applications of HPMS, other ion transport strategies, such as DC-
only optics, will be investigated. 
1.4.2 External Ion Trapping 
All HPMS work to date has used an EI or GDEI source, targeting gaseous and volatile 
analytes. Analytes are introduced into the mass spectrometer and ionized after entering the 
vacuum chamber. Because the analytes are already in the vacuum chamber (and often already in 
the trapping volume) when ionized, they have only a small amount of kinetic energy and can be 
easily trapped by the oscillating field of the CIT. For ESI, ions are generated at atmospheric 
pressure and must be transported into the vacuum chamber and the mass analyzer. Because the 
ions must be transported to the mass analyzer, they will likely have significantly more kinetic 
energy than ions generated inside the vacuum chamber. Recalling Equation 1.9, the 
pseudopotential well depth is a function of the dimension of the trap (via qz), and miniature CITs 
used for HPMS have reduced dimensions, and therefore reduced well depths, compared to 
conventional ion traps. The well depth affects not only the trapping capacity, but also limits the 
maximum possible kinetic energy of an ion that can be trapped. The increased kinetic energy of 
externally generated ions may make them more difficult to trap in the pseudopotential well of the 
CIT and must be considered carefully for ESI-HPMS.  
The trapping of externally generated ions in QITs has been considered extensively. 
Methods to trap external ions include “static trapping,” where the RF amplitude is constant 
throughout the injection period (traditional operation), and “dynamic trapping,” a strategy to 
improve trapping where the amplitude of the drive RF is adjusted during ejection to most 
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efficiently trap ions.110–113 Other methods to increase the number of trapped ions include simply 
increasing the flux of ions entering the trap with better optics (ion transfer efficiency, as in 
Section 1.4.1) and increasing the mass or pressure of the buffer gas to reduce the kinetic energy 
of the ions.112,114 The strategy of increasing the pressure of the buffer gas is of particular interest 
for HPMS. In this case, if ions can be efficiently transported to the mass analyzer, the increased 
pressure of HPMS may aid in the trapping of externally generated ions by reducing their kinetic 
energy.  
Externally generated ions have been trapped and analyzed under HPMS conditions both 
with glow discharge and EI. Cavanaugh demonstrated that ions could be produced and trapped 
with a filament 90 degrees off-axis from the axial dimension of the trap. Cavanaugh and 
Blakeman have both shown that the polarity of the glow discharge source can be reversed from 
EI operation to produce and accelerate ions toward the trap for mass analysis.46,115 While 
trapping externally generated ions in these cases shows promise, ions were still always produced 
in the same chamber as the mass analyzer. In contrast, ions produced by ESI outside of the 
vacuum chamber must undergo an additional transport step. 
1.4.3 Trapping and Analyzing Ions of High Mass and m/z  
An important feature of ESI is the ability to ionize molecules of high mass, especially 
peptides and proteins. Previous work with HPMS focused on the analysis of small molecules. 
Given the limited mass range of ion traps, parameters have to be adjusted to accommodate ions 
of higher m/z. Recalling Equation 1.7, the mass range depends on the applied voltage, the RF 
frequency, and the size of the trap. In order to trap ions with m/z values higher than previously 
analyzed (>150), appropriate scaling of these parameters is necessary. The voltage could be 
increased, but this is impractical for a miniature system for the same reasons discussed above. 
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The frequency can be decreased but must be sufficiently high (enough RF cycles per collision) to 
trap ions at HPMS pressures. Finally, the size of the trap can be decreased further. Blakeman 
used traps as small as r0 = 100 µm but increased the frequency to have roughly the same mass 
range and improve resolution.46 Traps of that size could be used for ESI-HPMS of larger 
molecules if the frequency were decreased, with the likely tradeoff of decreased mass resolution. 
For example, an order of magnitude decrease in frequency (i.e. 60 to 6 MHz) would result in a 
100-fold increase in the largest mass possible to be ejected, all else being equal. Thus, ESI-
HPMS analysis will consist of appropriately scaling the size of the trap, frequency, and voltage 
depending on the mass and m/z of the analyte.  
 In addition to higher m/z, ions from ESI are typically larger in mass and are multiply 
charged. As a result, space charge effects in ESI related to mass resolution and ion storage 
capacity will have to be considered. SLIT geometries will likely need to be employed in order to 
accommodate the larger, more highly charged ions. A possible benefit of the analysis of larger 
ions compared to smaller analytes is the relative size of the buffer gas, especially when air is 
used. The primary components of air (nitrogen, oxygen) have relatively high masses compared to 
many volatile and gaseous analytes, and scattering of ions in the trap and in ion transport can be 
problematic. Larger species like proteins will have a large mass relative to the buffer gas, so it is 
possible that they will be less scattered and more efficiently trapped than ions of lower mass.  
 
1.5 Current ESI-Miniature MS Interfaces 
Many miniature MS platforms have been developed for ESI and other atmospheric 
pressure ionization techniques. Many of these systems are covered in a recent review,116 so only 
a few ESI-MS systems will be discussed here. Most of the miniature MS systems are designed 
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for direct infusion of analytes, without a separation step beforehand. Many of the miniature 
systems use ambient ionization techniques such as desorption electrospray ionization (DESI) or 
paper spray ionization, which can provide useful information but would be difficult to use for 
complex mixtures.9,117 In addition, these systems still operate the mass analyzer at <10 mTorr 
pressures so the strenuous pumping requirements for an atmospheric inlet necessitates the use of 
a turbo pump for all of these platforms. One proposed solution to breaking the pumping barrier is 
to introduce ions discontinuously with a technique called discontinuous atmospheric pressure 
ionization, or DAPI.9,118 DAPI instruments use a pinch valve in the center of a capillary so that 
ions are collected and trapped in a linear ion trap at high pressure when the valve is opened. The 
valve is then closed, the mass analysis chamber is pumped down to a low pressure (<10 mTorr), 
then mass analysis is performed. Instruments developed using DAPI show promise, but they 
suffer from poor sampling rates (~1 Hz) and a power-hungry turbo pump is still required for 
mass analysis. 
A miniature CE separation has been coupled to a miniature mass spectrometer using a 
DAPI inlet, using a short capillary and nESI source.119 This system uses conventional silica 
capillaries for CE, and migration times were slow, so the low sampling rate of the DAPI 
configuration was adequate for their analysis. In addition, the system suffers from the 
conventional complexities of CE-ESI including injection and a sheath-flow interface. Finally, the 
system still requires a turbo pump and low pressures for mass analysis.  
A microchip CE-HPMS platform should provide several advantages over other similar 
miniature analytical platforms. HPMS reduces the pumping requirements and aids in reducing 
the size and cost of the instrument. Operation at high pressure should also facilitate continuous 
 24 
sampling, increasing the duty cycle of the instrument. The microchip CE platform is simple to 
operate, has a small footprint, and produces high efficiency and rapid separations. 
 
1.6 Objectives 
The primary objective of this work is to develop a miniature CE-MS platform integrating 
the microchip CE-ESI and HPMS technologies. Chapter 2 focuses on the initial efforts and 
development involved in integrating microchip CE-ESI with HPMS, including ion transport and 
tandem mass spectrometry of electrosprayed species. Chapter 3 discusses improvements and 
modifications made for the analysis of small molecules, specifically focusing on amino acids. 
Chapter 4 presents further modifications and optimization of optics and operational conditions 
for the analysis of large biomolecules, including intact proteins. The final chapter consists of 
conclusions and future directions. 
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1.7 Figures 
 
 
Figure 1.1: A) Picture of quadrupolar ion trap electrodes and B) Cross-sectional schematic of 
quadrupolar ion trap. The trap consists of a ring electrode and two endcaps. The dimensions of 
the trap are defined by the radial (r0) and axial (z0) dimensions shown in the schematic.  
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Figure 1.2: Theoretical regions of radial (r) and axial (z) stability for a quadrupolar ion trap, 
ploted in az, qz space. The areas labeled A and B correspond to important overlapping regions of 
r and z stability, where ions are stably trapped (reprinted from reference 120). 
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Figure 1.3: Zoom of region A from Figure 1.2, shown with iso-b lines, a parameter 
corresponding to the motion of the ion in the trap. Ions are stably trapped in the region bounded 
by the solid black lines. Under normal ion trap operational conditions with no DC voltage, ions 
lie along the qz axis. The voltage can be ramped and ions become unstable in order of increasing 
m/z at the point where qz is 0.908, labeled in the figure (reprinted from reference 120). 
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Figure 1.4: Equipotential lines for A) Quadrupole ion trp with hyperbolic electrodes where 
r0 = 10 mm, z0 = 7.07 mm and B) Cylindrical ion trap with planar electrodes and 
r0 = z0 = 5.0 mm. Near the center of the CIT, the field is largely quadrupolar (reprinted from 
reference 19). 
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Figure 1.5: Effects of pressure on mass spectra of 2-chloroethyl ethyl sulfide (CEES) in helium 
buffer gas with CIT r0 = 500 µm and RF at 6.73 MHz (reprinted from reference 46).  
  
 30 
 
Figure 1.6: Effects of buffer gas composition on mass spectra of p-xylene at 1 Torr with a CIT of 
r0 = 500 µm and RF at 10.0 MHz (reprinted from reference 46).  
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Figure 1.7: 3D cross-section of CIT (top) and SLIT (bottom). Both traps consist of a ring 
electrode and two endcap electrodes. The SLIT operates the same as the CIT but is stretched in 
the y-dimension labeled in the figure (reprinted from reference 52). 
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Figure 1.8: Traditional setup for capillary electrophoresis. Two buffer reservoirs are connected 
by a capillary, and high voltage is applied between the inlet and the outlet. Species migrate and 
optical detection (green circle) is performed near the outlet of the capillary (reprinted from 
reference 60). 
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Figure 1.9: Schematic of a typical CE-ESI microchip device. The device consists of buffer 
reservoirs (labeled with numbers), an injection cross, a serpentine separation channel with 
asymmetically tapered turns (see inset), a pumping channel that intersects the separation channel 
near the corner of the device, and an integrated ESI emitter (see inset). A copper electrode is 
used to isolate the voltage at the ESI emitter and the voltages applied to the reservoirs (reprinted 
from reference 60).  
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 Chapter 2: Initial Development of Electrospray Ionization Coupled with High Pressure 
Mass Spectrometry 
 
2.1 Introduction 
 Since its initial development, electrospray ionization (ESI) has significantly expanded the 
range of mass spectrometric analysis from gas phase and volatile molecules to include 
biomolecules and other liquid-borne analytes.1,2 ESI provides a facile method for coupling liquid 
phase separations, such as liquid chromatography (LC) or capillary electrophoresis (CE) with 
mass spectrometry (MS) detection.3,4 As a result, LC-MS has become a widely used analytical 
tool in fields such as proteomics,5 environmental monitoring,6,7 drug discovery and 
development,8 and clinical diagnostics.9,10 Despite their usefulness, conventional LC-MS systems 
are usually confined to dedicated laboratories because they are large, expensive, complex, and 
require significant amounts of power. The development of a smaller, less expensive, and simpler 
liquid phase separation/MS analytical platform could be applied to many of the same fields as 
traditional LC-MS systems, with the added potential for on-site analysis. The miniaturization of 
LC systems is limited by the need for a rugged system of pumps, valves, and tubing, while mass 
spectrometers are limited by low pressure operation, which requires bulky, fragile, and expensive 
turbomolecular pumps.  Many recent efforts have been made towards the miniaturization of both 
liquid phase separations and mass spectrometry,11,12 including a miniature CE separation system 
coupled with a miniature MS system.13 The combination of miniature separations platforms and 
mass spectrometry could be a low-cost, targeted alternative to conventional instrumentation. 
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With the goal of a fully miniature separation-MS analysis system, this chapter describes the first 
steps in coupling microfabricated ESI devices with high pressure mass spectrometry (HPMS). 
 Microfluidic-based ESI devices have small sample volumes, short analysis times, flow 
rates easily coupled to MS, and a small form factor that fits within the goal of a miniature 
analytical platform.14 Previous work from the Ramsey lab produced glass microchips with high 
performance, monolithically integrated ESI emitters that are also simple to fabricate. These 
devices were used to perform CE separations for many biomolecule analyses, with the separation 
channel terminating at the corner of the device that acts as an ESI emitter, resulting in a 
microchip-MS interface with no detectable band broadening.15–17 These microchips can be 
controlled with only DC voltage, have a small footprint (~2.5 x 6 cm), and give high efficiency 
separations, making them excellent candidates for a miniature CE-MS system. 
 Recently, high pressure mass spectrometry has been demonstrated as a viable method for 
the miniaturization of mass spectrometry.18,19 The strategy for HPMS utilizes miniature 
cylindrical ion traps (CITs) with sub-mm critical dimensions operated at elevated drive 
frequencies compared to conventional ion traps. Previous HPMS work focused on gas phase 
analysis of small organic analytes or xenon, with the maximum m/z analyzed not extending 
beyond 150 m/z. Most analytes of interest (proteins, peptides, amino acids) for ESI are 
substantially larger in size, so mass range considerations of the CIT are important. The mass 
range for a quadrupolar ion trap can be expressed as the maximum m/z ion that can be ejected 
from the trap:20 
 
 m
z max
= 
8Vmax
qmaxWRF
2 r02+ 2z02  2.1 
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where Vmax is the maximum RF drive voltage, qmax = 0.908 is a trapping parameter and constant, 
WRF is the drive frequency (2pf), r0 is the radius of the trap, and z0 is the axial dimension of the 
trap. If practical voltages are maintained (<1000 V0-p), the drive frequency and the size of the 
trap can be adjusted to tune the mass range of the instrument.21 This has been previously 
investigated where traps with r0 of 500 µm and frequencies between 6 and 10 MHz were used 
resulting in a mass range of about 70 to 140 m/z.18,19 With the goal of improving mass resolution, 
smaller traps (r0 < 500 µm) have been used, but the frequency was increased simultaneously so 
the mass range was roughly maintained.22 For many common analyses by ESI, the mass range 
may need to extend up to as much as 2000 m/z.  The frequency of the trap may need to be 
adjusted, the trap size reduced, or both to generate the desired mass range. 
 One of the difficulties associated with coupling ESI sources with MS systems is that ions 
must be transported into vacuum for mass analysis.23 The transmitted ion current from an ESI 
source can be reduced by up to three orders of magnitude when travelling through a capillary 
inlet. These losses occur mostly in transfer regions from a higher pressure to lower pressures (i.e. 
on either side of a capillary inlet),24 and two or more of these regions are usually present for 
traditional ESI-MS. Operation at HPMS pressures with air as a buffer gas, however, should 
simplify the ESI-MS interface. Given that ions may be introduced from atmospheric pressure 
directly into the mass analysis chamber, high pressure MS operation reduces the number of 
differential pumping regions necessary to perform MS analysis. In addition, many conventional 
mass spectrometers use a desolvation gas or an inert bath gas for normal operation, so the use of 
ambient air as a buffer gas would prevent dilution of analytes from the addition of other gases. 
These simplifications have the potential to yield improvements in instrument sensitivity by 
limiting possible ion losses and dilution factors compared to conventional instruments that have 
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one or more regions of differential pressure. 
 In this chapter, the initial developments in coupling microchip ESI sources with high 
pressure mass spectrometry via an atmospheric inlet and direct current (DC) optics are explored. 
Initial work here focuses on small biomolecules including amino acids and peptides. These are of 
interest as one application of a CE-HPMS system could be monitoring of amino acids for process 
control of bioreactors used to produce biopharmaceuticals. Monitoring amino acid concentration 
can be used to optimize growth conditions and monitor cellular activity in a cell culture or 
bioreactor.25 Analysis of peptides is of importance for QA/QC of biopharmaceuticals, 
identification and characterization of proteins, or to gain greater insight into cellular functions.26 
Parameters for miniature CIT operation are adjusted and optimized to create the desired mass 
range for the analysis of amino acids and peptides. CE-ESI-HPMS analysis is performed on 
peptide molecules and compared with CE-ESI-MS with a commercial mass spectrometer 
(Synapt G2). In addition, multiple stages of tandem mass spectrometry (MS/MS) up to MS4 are 
investigated as a tool for increasing the selectivity of an ion trap mass spectrometer operated 
under HPMS conditions. 
 
2.2 Experimental 
2.2.1 Materials and Reagents 
 HPLC grade acetonitrile and formic acid (99.9%) were obtained from Fisher Scientific 
(Fairlawn, NJ). Purified deionized water was obtained using a Nanopure Diamond water purifier 
(Barnstead International, Dubuque, IA). APDIPES (3-Aminopropyl di-isopropylethoxysilane) 
was obtained from Gelest (Morrisville, PA). Amino acids used for analysis were obtained from 
Fisher Scientific. Peptides bradykinin, methionine-enkephalin, thymopentin, and angiotensin II 
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were obtained from American Peptide Company (Sunnyvale, CA). Leucine enkephalin and 
acetaminophen used for MS/MS experiments were obtained from Sigma (St. Louis, MO). The 
background electrolyte (BGE) for all experiments was 50% acetonitrile, 49.9% water, and 0.1% 
formic acid (v/v/v, pH = 3.1). 
2.2.2 Microchip Design and Operation 
 Two microchip devices were used for this work: an infusion-ESI device and a CE-ESI 
device with a 46-cm serpentine separation channel, schematics of which are shown in Figure 2.1. 
Fabrication of these devices is described in detail in Appendix I. Channels for both devices were 
isotropically wet-etched to 10 µm deep and 70 µm wide. Devices were coated according to the 
coating procedures outlined in Appendix I. Briefly, devices were coated with APDIPES via 
chemical vapor deposition (CVD) using a LabKote CVD system (Yield Engineering Systems, 
Livermore, CA). The pumping (EO) channels for both devices were then functionalized with a 
20 kDa polyethylene glycol (PEG) reagent (NanoCS, Boston, MA). The PEG reagent terminates 
with an N-hydroxysuccinimide ester that reacts with the primary amine of the APDIPES surface, 
forming a covalent bond between the PEG chain and the surface coating. 
 Devices were operated as described in Appendix II. All voltages were applied via 
platinum wire electrodes and controlled with a custom LabVIEW program. For the infusion 
device, voltages applied were +5 kV at the EO reservoir and +0.5 kV at the S reservoir. Voltages 
applied to each reservoir for the CE-ESI devices are shown in Table 2.1. Operational voltages 
are shown in the column labeled Vrun. Injections were performed electrokinetically. To perform 
an injection, voltages were switched to the column labeled Vinj and then back to Vrun after the 
injection was complete. The applied voltages produced an electric field strength of 400 V/cm 
with an approximate flow rate of 165 nL/min.  
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2.2.3 Microchip ESI-MS 
 Electrospray ionization-high pressure mass spectrometry (ESI-HPMS) experiments were 
performed with a custom atmospheric interface and differentially pumped vacuum system. A 
schematic of a typical experimental setup is shown in Figure 2.2.  
 The microchip-ESI device (CE or infusion) was mounted on an adjustable x-y-z stage 
and positioned approximately 5-10 mm from the HPMS inlet capillary (items 1 and 2 in Figure 
2.2). A single-sided copper clad circuit board (M.G. Chemicals, Burlington, Ontario, Canada) 
was used to shield the ESI orifice on the chip from the voltages applied to the reservoirs (not 
shown). The corner of the microfluidic device extended about 5 mm through a slit in the board. 
The copper board was held at +1 kV for CE experiments and GND for infusion experiments. 
 The miniature CIT used for HPMS analysis was mounted in a custom differentially 
pumped vacuum chamber described previously.18 Ions were conducted into vacuum using a 
custom capillary interface, consisting of a stainless steel capillary (2 in Figure 2.2) that had 0.01 
in. ID, 0.0625 in. OD, and was 10 cm long (Valco Instruments Co., Inc., Houston, TX). The 
capillary was held in place by a Swagelok UltraTorr fitting (Solon, OH). Ions were typically 
accumulated for 5 ms before analysis. They were then scanned out of the trap and detected with 
an electron multiplier (6 in Figure 2.2) (Detech 2300, Detector Technology, Inc., Sturbridge, 
MA). A typical mass spectrum was an average of 30 to 1000 individual mass scans. Two sets of 
pumps were used for differentially pumping the chamber (7 in Figure 2.2). A dry scroll pump 
(SH-110, Agilent Technologies, Inc., Santa Clara, CA) was used on the mass analysis chamber 
(~1 Torr) and an Agilent TPS Bench turbomolecular pump (Model TV81M) backed by a dry 
scroll pump (SH-110) was used on the detector chamber (~10 mTorr). 
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 Miniature CIT electrodes were wet etched by Towne Technologies, Inc. (Somerville, NJ). 
Dimensions for the CITs were r0 = 250 µm, z0 = 325 µm, and endcaps had 200 µm hole 
diameters. Each ring electrode contained a single trap. Traps were assembled by manual 
alignment using alignment pins and holes etched through the electrodes. Electrodes were 
mounted to a custom plate with 125 µm kapton (polyimide) spacers between them. Drive RF 
waveforms were applied by a Rohde and Schwarz SMB 100A signal generator and amplified 
using a Mini Circuits TVA-R5-13 preamplifier and AR 305 power amplifier. The signal was 
resonated with a tank circuit, and applied frequencies ranged from 7 to 12 MHz. For MS/MS 
experiments, a small supplementary RF voltage was applied to the endcap closest to the inlet 
capillary using an AFG 3022B Function generator (Tektronix, Beaverton, OR). Custom 
LabVIEW software was designed to monitor, control, and collect data. A National Instruments 
PXIe-1073 data acquisition chassis was used to interface the electronics and LabVIEW software.  
 For comparison of CE separation detection, a Synapt G2 quadrupole-ion mobility-time-
of-flight mass spectrometer was used (Waters Corporation, Milford, MA). The Synapt G2 was 
operated at a rate of 90 ms per summed scan with an interscan delay of 24 ms (~9 Hz). The mass 
range was set to 300 to 1600 m/z. MassLynx software used to collect data was triggered by a 
custom LabVIEW program used to control voltages applied to the microchip. 
 
2.3 Results and Discussion 
2.3.1 Atmospheric Interface 
 Because the goal of this work is to develop an easy to operate, low-cost instrument, a 
simple interface to conduct ions from atmosphere into vacuum for HPMS analysis was designed. 
Typical atmospheric pressure interfaces for MS consist of capillary inlets or small apertures to 
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conduct ions into the first vacuum stage. Using this as a guide, a stainless steel capillary inlet 
was chosen for the initial atmospheric interface (2 in Figure 2.2). The ESI-HPMS interface 
developed here should have several advantages over conventional ESI-MS interfaces. 
Conventional ESI-MS interfaces consist of an atmospheric inlet, multiple regions of differential 
pressure, and complex ion optics – required due to the low-pressure operation of the mass 
analyzer. Because HPMS operates with pressures close to 1 Torr, the interface can introduce ions 
directly from atmosphere into the mass analyzer chamber via the capillary inlet with a simple 
vacuum fitting holding the capillary in place. In addition, minimal ion optics should be required 
to maximize ion transmission due to a shorter ion source-to-mass analyzer distance. 
 Four different capillary sizes, 0.005, 0.007, 0.01, and 0.02 in. ID were tested. No ions 
were observed with either the 0.005 or 0.007 in. ID capillaries. Pumping requirements proved too 
strenuous for the 0.02 in ID capillary, so a capillary with 0.01 in. ID was chosen for further 
development. A copper electrode (3 in Figure 2.2) was used to align the capillary with the 
entrance to the CIT and to accelerate ions toward the trap after exiting the capillary. The 
capillary and accelerating electrode were in electrical contact, and a voltage between +100 and 
+200 V was applied to the combination. In addition to alignment and acceleration, a focusing 
element was added to further improve sensitivity. A simple DC “gate” electrode (4 in Figure 2.2, 
r = 250 µm, 380 µm thick, spaced 125 µm from the endcap of the CIT) was inserted between the 
trap and the alignment electrode. The gate electrode focuses ions into the trap during the ion 
injection segment of the timing sequence and prevents ions from entering the trap during mass 
analysis. A timing diagram is shown in Figure 2.3. A positive voltage between +20 and +100 V 
is applied to the gate to focus ions into the trap during ion injection, and ground or a small 
negative DC voltage (-5 to -30 V) is applied to stop ions during the rest of the timing sequence. 
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The rest of the sequence contains a time for ions to cool in the trap, an instability scan (mass 
analysis) in which the RF amplitude is ramped to eject ions, and a clear step in which the RF 
amplitude is made very low so ions not ejected during the mass ramp are cleared from the trap 
before the next scan. If more ions enter the trap during the cool or mass ramp portions of the 
scan, they could interfere with mass analysis. The DC gate electrode efficiency was tested by 
gating of ions from BGE with the ion signal shown along with the RF voltage sequence in Figure 
2.4. A pulse of ions is observed during the desired ion injection time (0 to 4 ms in the figure), 
and no ions are observed during the ramp. Note the ion signal observed is from ions that are not 
trapped during the ion injection period. This behavior is expected because the sample does not 
contain any analyte. If the sample contained analyte, ions from the sample would be trapped and 
we would expect ion signal during the RF ramp/mass analysis portion of the sequence. The 
observation of this pulse demonstrates that the DC gate electrode can be used to efficiently 
control ion entrance into the CIT. 
 The amino acid histidine was used as the initial model analyte for the development of the 
microchip-to-MS interface. The infusion-ESI microchip was used so a constant source of ions 
was present. After optimization of the RF frequency and voltage to create the desired mass 
range, all twenty amino acids were separately infused and detected, shown in Figure 2.5, in order 
of increasing mass from bottom to top. Mass analysis was performed at a pressure of 1.2 Torr 
with ambient air as the buffer gas at a drive frequency of 10.2 MHz. Each spectrum was an 
average of 1000 individual mass scans. The mass range was approximately 70 to 220 m/z. The 
(M+H)+ peak for each amino acid is detectable, which should provide sufficient information for 
compound identification in a targeted analysis scenario. Many of the smaller amino acids have 
additional peaks in the spectra that have higher m/z than the protonated molecule. These peaks 
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likely correspond to either adducts or dimers of these amino acids, which is not unexpected due 
to the high concentration of the amino acids infused (100 µM). For most of the higher mass 
amino acids, additional peaks were observed below the (M+H)+ peak. These peaks likely 
correspond to fragments of the amino acids. To more easily view the spectra of these amino 
acids, a sample of four of the same spectra from Figure 2.5 are shown in Figure 2.6: proline, 
glutamic acid, histidine, and arginine. The (M+H)+ peaks in each of these spectra are easily 
identifiable and in the case of histidine and glutamic acids, fragments are also visible. ESI is a 
soft ionization technique, but operation at high pressures results in increased ion-buffer gas 
collisions, which can impart the energy required to induce fragmentation. In the future, these 
fragmentation patterns may aid in the identification of chemical species, including the 
differentiation of isobaric molecules. Detection of the twenty common amino acids demonstrates 
the ability to detect a range of analytes varying in size, polarity, and basicity. 
 Expanding the mass range of detectable analytes would increase the utility of an ESI-
HPMS system. For instance, a low cost, high throughput method for the detection of peptides 
could be used for QA/QC of biopharmaceuticals. As shown in Equation 2.1, the mass range can 
be extended by decreasing the RF drive frequency for a given RF drive voltage and trap 
dimension. To test this, the RF drive frequency was decreased to 7.1 MHz from 10.2 MHz, 
giving a predicted mass range of 300 – 725 m/z compared to a mass range of 75 – 225 m/z for the 
amino acid analysis. 
 Using this strategy, an infusion-ESI-HPMS spectrum of a small peptide, thymopentin 
(RKDVY, (M+H)+ m/z  = 681), was collected (Figure 2.7). Mass analysis was performed at a 
pressure of 1.3 Torr with ambient air as the buffer gas. The spectrum shows a large peak at 
around m/z 341, corresponding to the doubly charged species, (M+2H)2+. The protonated 
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molecule is also observed at m/z 681. There are a number of peaks that appear between m/z 360 
and m/z 500, which likely correspond to fragments of thymopentin. The analysis and detection of 
this peptide demonstrates that the mass range of the CIT can be extended to at least m/z 681, with 
the potential to further extend the mass range by tuning the RF drive frequency, drive voltage, 
and trap size. 
 With respect to sensitivity, the signal-to-noise ratio (S/N) for thymopentin was 
significantly greater than the S/N observed for the amino acids, ~75x higher. One explanation for 
the smaller S/N observed for amino acids versus peptides could be due to less efficient capture of 
small molecules from scattering before entering the trap. The amino acids are much closer in 
mass to the buffer gas molecules than the peptide, so their trajectories are more likely to be 
altered by a collision with a buffer gas molecule than that of thymopentin. This experimental 
setup used very simple ion optics, consisting only of one accelerating electrode, and one DC gate 
lens. The discrepancy in S/N could be resolved with more complex ion optics for more efficient 
ion focusing and collection, such as an ion funnel.24 Despite the difference in S/N between 
analytes of different mass, this simple inlet interface is an effective way of introducing ions from 
atmospheric pressure into vacuum for HPMS analysis. 
2.3.2 CE-ESI-MS of Peptides 
 After demonstrating the viability of the atmospheric interface, the HPMS system was 
assessed as a detector for CE separations and compared with a commercial mass spectrometer, 
the Waters Synapt G2. Normalized base peak intensity (BPI) electropherograms of a standard 
peptide mixture (methionine enkephalin, angiotensin II, bradykinin, and thymopentin) detected 
with the HPMS system and the Synapt G2 are shown in Figure 2.8. Fluorescein was added to the 
mixture as a dead time marker. 
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 The separation field strength was 400 V/cm with a flow rate of approximately 
165 nL/min. About 7 fmol of peptide mixture was injected during a 0.5 s electrokinetically gated 
injection. The CIT was operated at 1.2 Torr with an RF drive frequency of 7.1 MHz. As shown 
in the traces in Figure 2.8, fluorescein and the four peptides in the standard mixture were 
separated and detected. Comparing the two electropherograms, the average S/N of the four 
peptides was 69 using HPMS and 437 using the Synapt G2. The calculated average separation 
efficiencies were 445,000 theoretical plates using HPMS and 490,000 theoretical plates using the 
Synapt G2. Both mass spectrometers were able to detect these fast and highly efficient 
separations (average full-width at half maximum (FWHM) = 0.58 ± 0.04 s), with the discrepancy 
resulting from differences in mass spectral sampling rate. The difference in sampling rate is 
illustrated in Figure 2.9, showing individual data points collected over the peak in the 
electropherogram corresponding to bradykinin (solid circles). The bottom trace shows the HPMS 
system, where there were only about three data points collected over the width of the peak, 
corresponding to a sampling rate of about 3 Hz. In contrast, the sampling rate for the Synapt G2 
(top trace) was about three times as fast, or about 9 Hz, with nine points collected over the course 
of the same peak. The HPMS system is limited by the time required to accumulate, analyze, and 
clear ions from the trap as displayed in the timing sequence shown in Figure 2.3. In this case, a 
typical sequence involved ion injection/accumulation times of about 4 to 5 ms, a cool time of 
0.5 ms, a mass analysis scan of 5 ms, and a clear time of 1 ms. As shown in Figure 2.4, a typical 
full scan function was about 11 ms. With improvements in sensitivity, the ion accumulation time 
could be minimized, and the duty cycle, and therefore the sampling rate, increased. Detection of 
these peptides shows that a miniature CIT based mass spectrometer operated at high pressure can 
be used for detection of fast separations with narrow peak widths. Although the Synapt G2 
 53 
showed about six times better S/N, this simple comparison demonstrates the viability of an 
HPMS system using a mini-CIT as a detector for the separation of biomolecules. 
 For mixtures like these peptides, the HPMS system potentially offers a simple and 
inexpensive alternative to a large commercial instrument like the Synapt G2. The miniature MS 
system can provide useful mass spectral information for label-free detection and identification of 
chemical species for targeted applications. A comparison of the mass spectra of bradykinin from 
both mass spectrometers acquired during the CE separations is shown in Figure 2.10. Some 
similar features can be observed in the two spectra, most notably the (M+2H)2+ peak around 
m/z 531. A feature corresponding to the (M+3H)3+ peak is also observed around m/z 354. The 
most obvious difference in the two spectra is the observed peak width (FWHM: 12.0 m/z with 
HPMS; 0.026 m/z with the Synapt G2). Wider peaks are expected with HPMS due to increased 
analyte-buffer gas collisions with higher pressure operation and a larger buffer gas (ambient air). 
Even with increased peak widths, a mass spectrum combined with CE migration time provides 
sufficient information for identification of chemical species, especially for an application where 
the goal is detection of known target analytes. Note that if narrower peak widths are needed, 
peak widths could be improved with higher RF frequency operation and the use of smaller traps 
to maintain the mass range, and different trap geometries or arrays of CITs could make up for 
lost charge capacity.27,28 In the case of a miniature bench top instrument, it might be possible to 
use helium buffer gas to further improve resolution. Resolution could also be improved by 
applying a small RF voltage to one or both endcaps of the trap to perform resonant or double 
resonant ejection.29,30  
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2.3.3 Tandem Mass Spectrometry 
One of the advantages of quadrupolar trap analyzers is the ability to perform tandem mass 
spectrometry (MS/MS) with a single mass analyzer.29 MS/MS analysis can significantly increase 
the selectivity of a mass spectrometer by performing multiple stages of fragmentation and mass 
analysis. With the loss of some resolution when using HPMS, tandem mass spectrometry would 
greatly increase the utility of the platform.  
Tandem mass spectrometry in an ion trap is most often done by isolating a single peak in a 
mass spectrum and then fragmenting that peak with collision-induced dissociation (CID). 
Briefly, a small supplementary AC voltage is applied to one or both endcaps that excites ion 
motion in the trap. The excited ions collide with neutral buffer gas molecules, and the kinetic 
energy from those collisions is converted to internal energy, which can be sufficient to fragment 
those ions. MS/MS using CID under HPMS conditions has been shown previously with mostly 
small, organic molecules as targets to improve mass spectral selectivity.31 MS/MS would also be 
useful for improving the identification of biologically relevant molecules analyzed by ESI-
HPMS and is used frequently in conventional ESI analyses for the identification of proteins, 
peptides and other biological compounds of interest.32  
Infusion ESI-MS/MS with tryptophan as an analyte is shown in Figure 2.11. The CIT was 
operated at 7 MHz and a pressure of 1.2 Torr, with ambient air as the buffer gas. The black trace 
(labeled MS) shows an MS scan where the protonated molecule of tryptophan is observed, along 
with what is presumed to be a proton bound dimer. The blue trace (labeled isolation) shows the 
isolation of the proton bound dimer. The isolation was performed using a partial instability scan. 
The RF amplitude was ramped to the point just before the ejection of the dimer, ejecting all 
species of lower mass and isolating species of higher mass, in this case, the proton bound dimer. 
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After isolation, the dimer was excited for 5 ms with an axial RF voltage on one of the endcaps at 
0.5 MHz and an amplitude of 4.8 Vp-p. The red trace (labeled MS/MS) then shows the result after 
isolation and excitation of the dimer. With energy added from the supplementary RF, some of 
the parent ion (dimer) is fragmented to the monomer. 
An advantage of ion traps is that they can perform multiple stages of tandem mass 
spectrometry, or MSn with it having been shown in a conventional trap up to MS12. This 
capability can further increase the selectivity of the instrument.33 Different stages of isolation and 
excitation of clusters of acetaminophen from an infusion up to MS4 are shown in Figure 2.12. 
The first stage (A) shows an MS scan of the acetaminophen clusters. In the second stage (B), the 
highest mass (latest ejecting) cluster (labeled 1) is isolated and fragmented. In the third stage (C), 
the highest mass fragment from the MS2 scan (labeled 2) is isolated and fragmented. Finally, the 
fourth stage (D) shows the isolation of the highest mass ion from the MS3 scan (labeled 3) and a 
small peak corresponding to the last fragment (labeled 4). The mass spectra and scan functions 
used to produce each stage of MS are shown in Figure 2.13. The same excitation frequency and 
voltage (0.3 MHz, 8.5 Vp-p) were used for each excitation, but for varying lengths. The ability to 
use the same frequency indicates that broadband excitation can be performed under HPMS 
conditions. This is likely due to the fact that the secular frequencies of the ions in the trap are not 
well defined because of the large number of ion-buffer gas collisions at high pressure.31 It is 
important to note that only the highest mass ion was isolated in each case using a partial 
instability scan by ramping the drive RF amplitude to just below the ejection voltage of the 
highest mass ion. Ion traps also have the potential to target and isolate other peaks in the mass 
spectrum using techniques like apex isolation or SWIFT.34,35 These types of isolation have been 
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performed with HPMS previously and could be implemented to further improve the selectivity of 
HPMS.  
The discussion of tandem mass spectrometry has focused on fragmentation of loosely 
bound species, but molecules like peptides can be much more difficult to fragment because there 
are a larger number of bonds over which internal energy can be distributed. Leucine enkephalin 
(YGGFL) is an endogenous neurotransmitter often used as a mass spectral calibrant and 
prototype molecule to study peptide fragmentation36 and was used to test CID of peptides under 
HPMS conditions. A full mass spectral scan of YGGFL (black trace) shown in Figure 2.14 with 
a spectrum of YGGFL after isolation and subsequent CID. The drive RF frequency was 
7.1 MHz, and the pressure was 1.0 Torr of ambient air. The excitation voltage for the CID 
spectrum was 8 Vp-p, applied for 0.5 ms at 0.1 MHz. Both spectra are dominated by the 
protonated molecule, ejected at about 3 ms. Some of the fragments observed in the full spectrum 
are produced again after CID. There is also a shoulder on the protonated molecule that was not 
present in the full scan, indicating that MS/MS may provide new information to aid in 
identification of species. More efficient fragmentation would aid in peptide identification, but the 
fragmentation of YGGFL shows MS/MS of peptides under HPMS conditions is possible. 
 
2.4 Conclusions  
The first steps (capillary interface and DC gate electrode) in coupling ESI with HPMS 
have been demonstrated. A simple atmospheric interface was designed to conduct ions from 
atmosphere into the ion trap in vacuum. Microchip infusions and CE separations were performed 
using HPMS as a detector operated at pressures greater than 1 Torr with ambient air as the buffer 
gas, demonstrating the viability of a miniature CE-ESI-MS system. Finally, MS/MS under 
HPMS conditions with electrospray-infused analytes was performed. The next chapters discuss 
 57 
improvements on the initial development of ESI-HPMS described here for specific analytes and 
applications. 
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2.5 Figures and Tables 
 
 
Figure 2.1: Schematics for capillary electrophoresis (A) and infusion (B) glass microfluidic 
devices. All channels were etched to a depth of 10 µm. Reservoirs are designated with circles 
and indicate sample (S), background electrolyte (BG), sample waste (SW), and electroosmotic 
pump (EO). The microchip in A consists of an injection cross, a 46-cm serpentine separation 
channel, and an electroosmotic pumping channel. The infusion device (B) consists of a 5.5-cm 
channel and an electroosmotic pumping channel, and both reservoirs are filled with the sample. 
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Figure 2.2: Experimental setup (not to scale) for ESI-HPMS with (1) Glass microchip with 
electrospray, (2) stainless steel capillary and UltraTorr fitting, (3) accelerating electrode, (4) gate 
electrode, (5) trap electrodes; two endcaps (BeCu) and ring (Cu), (6) electron multiplier detector, 
and (7) vacuum pumps. 
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Figure 2.3: Timing diagram for HPMS experiments. The  voltage applied to the gate electrode 
(gate voltage) is high during the ion injection portion and low during the rest of the scan. After 
ion injection, the RF amplitude is constant while the trapped ions are given time to cool. The RF 
amplitude is then ramped to perform the mass analysis scan. The RF amplitude is then reduced to 
near-zero and any ions remaining after the ramp are cleared from the trap before the next scan 
begins. 
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Figure 2.4: Ion gating with the gate electrode using background electrolyte as the sample. The 
black trace shows ion signal, and the red trace shows the RF ramp (arbitrary units). The signal 
from 0 to 4 ms shows that ions can be efficiently gated with the electrode; the voltage on the gate 
electrode is high during this point and low during the rest of the scan. The spikes at the 
beginning of the pulse are a turn-on feature from the detector. 
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Figure 2.5: Infusion-ESI-HPMS spectra of the twenty common amino acids. Each amino acid 
was infused separately at 100 µM in BGE. The drive RF was 10.2 MHz, and the buffer gas was 
ambient air at 1.2 Torr. *indicates (M+H)+  
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Figure 2.6: Infusion-ESI-HPMS spectra of four amino acids (100 µM) shown in Figure 2.5. The 
drive RF was 10.2 MHz, and buffer gas was ambient air at 1.2 Torr. 
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Figure 2.7: Infusion-ESI-HPMS spectrum of 5 µM thymopentin in BGE. The drive RF was 
7.1 MHz, and the buffer gas was ambient air at a pressure of 1.3 Torr. 
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Figure 2.8: BPI electropherograms of a peptide mixture with a 46-cm long separation channel 
CE microchip with HPMS (black) and Synapt G2 (red) detection. Fluorescein (*), Methionine 
Enkephalin (1), Angiotensin II (2), Bradykinin (3), Thymopentin (4) were the analytes. 
Approximately 7 fmol of peptide mixture was injected during a 0.5 s gated injection. The 
separation field strength was 400 V/cm. 
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Figure 2.9: Sampling rate comparison of HPMS (black) and Synapt G2 (red) over the bradykinin 
peak shown in Figure 2.8 (peak 3). About 9 points per peak are observed with G2, and about 3 
points per peak are observed with HPMS. 
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Figure 2.10: Sample mass spectra of bradykinin from A) HPMS and B) Synapt G2. 
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Figure 2.11: Infusion-ESI-HPMS, isolation, and MS/MS of tryptophan and tryptophan dimer. 
The black trace shows a full MS scan. The blue trace shows the isolation of the dimer. The red 
trace shows the HPMS scan result after isolation and excitation of the dimer with a small axial 
potential (4.8 Vp-p). 
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Figure 2.12: Isolation and excitation of acetaminophen clusters at MS stages up to MS4. 
A) Initial MS scan without isolation or excitation. B) Isolation of Peak 1 and fragmentation. 
C) Isolation of Peak 2 and fragmentation. D) Isolation of Peak 3 and fragmentation to Peak 4. 
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Figure 2.13: Stages of MS and scan functions for acetaminophen clusters/adducts up to MS4. The 
last ramp in each sequence is the mass analysis scan, and the previous ramps (partial instability 
scans) are used to isolate the highest mass ion. 
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Figure 2.14: Infusion-ESI-HPMS and MS/MS of leucine enkephalin. Some of the fragment 
features in the MS scan (black trace) are reproduced after the protonated molecule is isolated and 
fragmented. A shoulder on the protonated molecule also appears after excitation. 
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Table 2.1: Operational voltages for CE-ESI device at each reservoir during CE run and 
injections. 
 Vrun (kV) Vinj (kV) 
S -14 -14 
BG -14 -13 
SW -12 -13 
EO +6 +6 
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 Chapter 3: Investigation of ESI-HPMS for Small Molecule Analysis 
3.1 Introduction 
While small, volatile, and gas phase molecules were the targets for initial HPMS 
development using an electron ionization or glow discharge ion source, there are many 
applications where small, nonvolatile molecules are of interest. Drug characterization and 
validation for both production and forensics/screening,1–4 environmental monitoring,5,6 and many 
metabolomics applications7–10 necessitate detection of small, nonvolatile chemical species. These 
targets are often in complex matrices and necessitate a separation step prior to mass spectrometry 
(MS) analysis, usually by liquid chromatography (LC) or capillary electrophoresis (CE) coupled 
to MS via electrospray ionization (ESI). Many of these applications involve targeted (rather than 
discovery) analysis and would benefit from analysis on-site, making microchip CE-HPMS a 
good alternative to conventional LC and CE-MS methods.  
Initial developments of ESI-HPMS were discussed in Chapter 2 and involved the analysis 
of small molecules, including amino acids, but there are many improvements that can be made to 
enhance the performance of the platform. The mass resolution of peaks shown in Chapter 2 could 
be improved by increasing the drive frequency applied to the ion trap. Equation 1.6, reproduced 
here as Equation 3.1, shows the proportional relationship between resolving power (m/Dm), 
pressure (P), and frequency (W).11 
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If the pressure remains constant, an increase in drive frequency will improve the resolving 
power. However, if the frequency is increased, the mass range is decreased if all other 
parameters remain constant. Equation 1.7 shows the maximum mass that can be ejected from a 
trap and is reproduced as Equation 3.2:12 
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m
z
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where m/z is the mass-to-charge ratio, Vmax is the maximum amplitude of the drive RF voltage, 
qmax is the trapping parameter and constant (usually 0.908), and r0 and z0 are the dimensional 
parameters of the trap. In order to maintain the mass range when increasing the RF drive 
frequency and maintain practical voltages, the size of the trap must be decreased. For the work in 
this chapter, the drive frequency was increased up to 30 MHz, about three times higher than 
previous work, and the trap size was decreased to critical dimensions of about 100 µm.  
 With a decrease in trap size, there is a corresponding decrease in the number of ions that 
can be stored in the trap without loss in performance. In order to make up for the loss of trapping 
capacity of miniature cylindrical ion traps (CITs), arrays of CITs have been used.13–15 However, 
heterogeneity in the performance of the elements of the array may lead to decreased resolution. 
An alternative to CIT arrays to improve trap capacity is the stretched length ion trap, or 
SLIT.16,17 The SLIT operates in the same manner as a CIT, but the volume of the trap is stretched 
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in one dimension. For the smallest trap dimensions (~100 µm), SLIT traps were used to increase 
the ion storage capacity.  
 While changes to the mass analyzer geometry and operation can improve performance of 
the instrument, the transmission of ions to the mass analyzer is equally important to overall 
instrumental utility. One method to increase ion transmission is to improve the inlet geometry. 
Capillaries of different inner diameters and lengths can be used, or orifice inlets can be used in 
place of capillaries. Aperture or orifice inlets can use a smaller ID than capillaries and produce 
the same conductance limit, but their smaller length reduces the possibility of ion collisions with 
the wall of the inlet and may improve ion transmission. Both types of inlets are regularly 
implemented in mass spectrometry instruments,18 so both inlets were investigated to optimize ion 
transmission. Another way to increase ion transmission is improved ion optics. An electrode or 
“gate” lens with approximately the same dimensions as the ring electrode was used for focusing 
and gating ions in the previous chapter, but different optics could produce better ion focusing. 
Tube lenses have been used previously to focus ions from the inlet capillary in the first region of 
a commercial mass spectrometer,19 which operates at approximately the same pressure as HPMS. 
Therefore, using a tube lens in an HPMS system, ion focusing can be improved while still 
maintaining simple operation (i.e. only DC voltages). To help guide the design process, 
simulations were performed to optimize tube lens geometry before implementing the tube lens 
experimentally.  
 Two applications were chosen for proof-of-concept demonstration of the platform to take 
advantage of the improved sensitivity and resolution. These include monitoring the components 
of cell growth media for bioreactor monitoring and detection of opiates in urine for forensics or 
screening.  
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 Biotherapeutics, particularly monoclonal antibodies (mAbs), represent a growing portion 
of clinical drugs and much work has been done to characterize the drug product.20–22 The 
production of mAbs is a complex process involving cell growth followed by a series of 
purification and filtration steps.23 Proper cell growth is critical for many applications, including 
biotherapeutics to maximize protein yield, so monitoring the cell growth process is important.23–
27 Therefore, monitoring the composition of the medium as cells consume the various 
components is a way for monitoring cell growth progress. Being able to monitor the process on 
the production plant floor would be advantageous as it would eliminate the need for transport to 
a central laboratory. This could also decrease reaction times for adding key nutrients to the 
bioreactor to maintain optimal growth conditions by providing information in a timely manner. A 
compact microchip CE-ESI-HPMS system could provide an inexpensive and rapid strategy to 
monitor the components in growth media at the source. The time scale for cell growth is on the 
order of hours, while the typical analysis time for CE-HPMS is usually under 5 min, presenting 
the opportunity for real-time monitoring of cell growth. Thus, microchip CE-HPMS was 
explored here for monitoring cell growth via measurement of components, specifically amino 
acids, contained in the growth medium. 
 Another potential application of a miniature CE-HPMS platform is the detection of drugs 
of abuse in a forensic or screening setting, where rapid results are critical. Traditional drug 
analysis is performed in a “two-tiered” system where field measurements are performed before 
sending samples to a central lab.28,29 In the lab, analysis is typically performed by gas 
chromatography (GC) or LC methods coupled to MS, which are well characterized and 
considered the standard for many of these analyses.28,30 A microchip CE-HPMS platform may 
provide an inexpensive alternative to the standard LC and GC-MS analyses, and if made portable 
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enough for use in the field, the platform could eliminate the need for the “two-tiered” system. 
There are many possible drug targets for this analysis. Opiates are a commonly abused class of 
drugs, with over 2 million Americans having a substance abuse disorder related to prescription 
drugs in 2016.31 Because of their prevalence and high rate of abuse, opiates were chosen as the 
target analytes for this work.  
 This chapter outlines improvements in the CE-HPMS platform for the analysis of small 
molecules presented in Chapter 2 along with a demonstration of two potential applications for 
the technology. A tube lens was evaluated with SIMION simulations before experimental 
validation. Amino acid standards were then analyzed before attempting to monitor their 
consumption as a function of cell growth. Finally, opiate standards were analyzed before 
extracting and analyzing codeine in a urine sample.  
     
3.2 Experimental 
3.2.1 Materials and Reagents 
HPLC grade acetonitrile, methanol, and formic acid (99.9%) were obtained from Fisher 
Scientific (Fairlawn, NJ). Purified deionized water was obtained using a Nanopure Diamond 
water purifier (Barnstead International, Dubuque, IA). (3-Aminopropyl)di-isopropylethoxysilane 
(APDIPES) was obtained from Gelest (Morrisville, PA). NHS-PEG450 was obtained from 
NanoCS (Boston, MA). Individual amino acids were obtained from Fisher Scientific, and the 
mix of amino acid standards was obtained from Promega (Madison, WI). Drug standards were 
obtained from Cerilliant (Round Rock, TX). The background electrolyte (BGE) for most 
experiments was 49% methanol, 2% formic acid, and 49% water (v/v/v pH = 2.8). For analysis 
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of the drug standards, the BGE was 50% acetonitrile, 1% formic acid, and 49% water 
(v/v/v pH = 3.1).  
The cells used for amino acid consumption experiments were Escherichia coli K-12 
MG1655 strain. The cells were grown for varying amounts of time in Luria-Bertani growth 
medium prepared in-house and stirred in an incubator at 37 °C. Optical density measurements 
were made at 600 nm (OD600) using a Biomate 3S UV-Vis spectrophotometer (Thermo 
Scientific, Waltham, MA).  
3.2.2 Microchip Design and Operation 
Three different microchip devices were used for this work: an infusion-ESI device and two 
CE-ESI devices with either a 10-cm or a 23-cm separation channel. Device fabrication and 
coating details are outlined in Appendix I. Briefly, the devices were wet etched to a depth of 
10 µm and full width of 70 µm. The devices were then coated with APDIPES via chemical vapor 
deposition (CVD). All APDIPES coated channels were then functionalized with 20 kDa PEG in 
order to suppress the EOF.  
Operation of the devices is described in detail in Appendix II. All voltages were applied 
with platinum wire electrodes controlled by a custom LabVIEW program. Pressure to the devices 
was applied with 2 psi of air gated by 3-way valves from Clippard (Cincinnati, OH). For infusion 
devices, +5 kV was applied to one reservoir along with 2 psi pressure to facilitate electrospray. 
No voltage (GND) was applied to the other reservoir. For analysis of the opiate standards, a 
23-cm CE-ESI device was used, and injections were performed electrokinetically as described in 
Chapter 2. Run voltages of +20 kV were applied to the top (sample) and waste, +18 kV was 
applied to the BGE reservoir, and +2 kV was applied to the pumping channel reservoir. For all 
other experiments, a 10-cm CE-ESI device was used and injections were performed 
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hydrodynamically. To perform injections, voltages were turned off, and pressure was applied to 
the sample reservoir and a reservoir containing BGE for 5 to 40 s, then pressure was applied only 
to the reservoir containing BGE for 1 second. The voltages were then turned on, and normal zone 
electrophoresis began. Voltages were operated at up to +16.5 kV for the BGE reservoir and up to 
+2 kV for the pumping reservoir. Pressure was provided to the pumping reservoir to provide the 
flow necessary for electrospray. 
3.2.3 Microchip ESI-HPMS 
Electrospray ionization-high pressure mass spectrometry (ESI-HPMS) experiments were 
performed with a custom atmospheric interface and differentially pumped vacuum system 
adapted from the system described in Chapter 2, but redesigned with a chamber with much 
smaller form factor, approximately 2.5 x 2.5 x 12 cm compared to 10 x 10 x 20 cm used 
previously. A CAD drawing of the vacuum chamber and MS components is shown in Figure 3.1. 
Two different inlets and two types of optics were used: a capillary or an aperture inlet and a 
“gate lens” or tube lens for optics. For simplicity, only the aperture as the inlet and tube lens as 
the optic element are shown in Figure 3.1. 
The microchip-ESI device (CE or infusion) was mounted on an adjustable x-y-z stage and 
positioned approximately 5-10 mm from the HPMS inlet aperture or capillary. A single-sided 
copper clad circuit board (M.G. Chemicals, Burlington, Ontario, Canada) was used to shield the 
ESI orifice on the chip from the voltages applied to the reservoirs (not shown). The corner of the 
microfluidic device extended about 5 mm through a slit in the board. The copper board was held 
at +0.5 kV for all experiments. 
Ions were conducted into the chamber using either a 250 µm ID capillary (Valco 
Instruments Co., Inc., Houston, TX) or a 50 µm ID aperture (Lenox Laser, Glen Arm, MD). DC 
 83 
voltages up to +265 V were applied to the capillary. The ions were then focused into the trap 
using either a 560 µm ID “gate lens” or a 3 to 6 mm ID tube lens, both spaced 140 µm from the 
entrance of the front endcap of the trap using a teflon spacer. Only DC potentials were used to 
focus ions. A positive voltage between +20 and +265 V was applied to the gate or tube during 
ion accumulation, and a negative voltage of -50 V or GND was applied during other parts of the 
scan to prevent ions from entering the trap during mass analysis. 
Miniature CIT and SLIT electrodes were wet etched by Towne Technologies, Inc. 
(Somerville, NJ). Dimensions for the CITs were r0 = 280 µm, z0 = 330 µm, and endcaps with 
210 µm hole diameters. Dimensions for the SLITs were x0 = 100 µm, z0 = 117 µm, and SLIT 
aperture endcaps had full widths of 165 µm. Each ring electrode contained a single trap. Traps 
were assembled by manual alignment using alignment pins and holes etched in the electrodes. 
Electrodes were mounted to a custom plate with 140 µm (CIT) or 55 µm (SLIT) teflon (PTFE) 
spacers between them. Drive RF waveforms were applied by a Rohde and Schwarz SMB 100A 
signal generator and amplified using a Mini Circuits TVA-R5-13 preamplifier and AR 305 
power amplifier. The signal was resonated with a tank circuit, and applied frequencies ranged 
from about 7 to 31 MHz. A small supplementary RF voltage was applied to the endcap closest to 
the inlet using an AFG 3022B Function generator (Tektronix, Beaverton, OR) to perform 
resonant or double resonant ejection. Custom LabVIEW software was designed to monitor, 
control, and collect data. A National Instruments PXIe-1073 data acquisition chassis was used to 
interface the electronics and LabVIEW software. 
Ions were accumulated between 1 and 30 ms before analysis. They were then scanned out 
of the trap and detected with an electron multiplier (Detech 2300, Detector Technology, Inc., 
Sturbridge, MA) connected to a current preamplifier (SR570, Stanford Research Systems, 
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Sunnyvale, CA). A typical mass spectrum was an average of 10 to 1000 individual mass scans. 
Two sets of pumps were used for differentially pumping the chamber. A dry scroll pump 
(SH-110, Agilent Technologies, Inc., Santa Clara, CA) was used on the mass analysis chamber 
(~1 Torr) and an Agilent TPS Bench turbomolecular pump (Model TV81M) backed by a dry 
scroll pump (SH-110) was used on the detector chamber (~30 mTorr). 
For comparison of the separation and detection of the drug standards, a Synapt G2 
quadrupole-ion mobility-time-of-flight mass spectrometer was used (Waters Corporation, 
Milford, MA). The Synapt G2 was operated at a rate of 90 ms per summed scan with an 
interscan delay of 24 ms (~9 Hz). The mass range was set to 50 to 1000 m/z. MassLynx software  
used to collect data was triggered by a custom LabVIEW program used to control voltages 
applied to the microchip. 
 
3.3 Results and Discussion 
3.3.1 SIMION Simulations of Tube Lens 
Ion simulations performed by collaborators at 908 Devices, Inc. motivated the use of a 
tube lens to focus ions into the trap. Ion trajectories were modeled with SIMION 8.1 software 
(Scientific Instrument Services, Inc. Ringoes, NJ) using a hard-sphere collision model with SDS 
(statistical diffusion simulation) program to predict the interaction of ions with background 
nitrogen gas at 1 Torr. All ions were set to have a mass of 120 Da and a +1 charge. The ions 
were generated at the exit of an electrode representing a capillary inlet with either a gate 
electrode or a tube lens. Only DC voltages were applied to the capillary and the ion optics.  
The simulation results are shown in Figure 3.2. The first set of simulations used a capillary 
and a gate lens. The capillary was held at +50 V, the gate was held at +30 V, and the other 
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electrodes are grounded. A potential energy (PE) surface generated by SIMION is shown in 
Figure 3.2a with these parameters. There is an initial downhill field emanating from the 
capillary, but then it rises back uphill on approach to the gate electrode. In addition to collisions 
with buffer gas molecules, this field might impede ions traversing from the capillary to the trap. 
Upon exiting the gate electrode, there is a downhill and slight focusing field going towards the 
trap, indicating that the element should focus ions into the trap if they persist through the hole in 
the electrode. Figure 3.2b shows ion trajectories when no gas flow is present and where ions will 
only move in the presence of an electric field. In this case, the electric field created by the 
voltage applied to the capillary is not strong enough to drive ions through collisions with buffer 
gas molecules towards the gate electrode and the trap, and instead they turn around toward the 
inlet. Figure 3.2c shows ion trajectories with the same voltages applied in Figure 3.2b but with 
gas flow of 350 m/s applied in the y direction toward the trap. With the gas flow, ions are 
conducted from the capillary, through the gate lens, and into the trap. The magnitude of this gas 
flow is unrealistic over this distance, but it demonstrates that the primary driving force 
conducting ions from the capillary into the trap in previous experiments was not the electric field 
but the gas flow from the capillary through the chamber. 
An alternative to gate lenses are tube lenses into which the outlet of the capillary can be 
inserted. A PE surface of the capillary with a tube lens of 5 mm length and 5 mm ID is shown in 
Figure 3.2d. The voltage applied to the capillary was +50 V, the voltage applied to the tube was 
+30 V, and the other electrodes were held at GND (the same voltages as Figure 3.2a). With the 
addition of the tube lens, there is a downhill or flat path spanning from the capillary to the trap. 
The inward slope of the potential surface at the edges and the exit of the tube lens suggest that it 
will act as a focusing element as well. Figure 3.2e shows ion trajectories with the new geometry 
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and no gas flow. In this case, the electric field is sufficient to drive ions to the trap, and no gas 
flow is necessary. In addition, the tube lens provides a focusing effect for the ions into the trap, 
giving them a narrower dispersion than the simulation of the gate electrode with gas flow in 
Figure 3.2c. While some gas flow is present in reality, these simulations indicate that, with a tube 
lens, the primary driving force for ion transport will be the electric fields. The results of these 
simulations suggest that a tube lens would be an improved optic element over a shorter “gate 
lens,” and still only require DC voltages. This motivated a switch in instrumentation 
implementation to use of the tube lens as the primary ion optic element. 
3.3.2 Tube Lens ID Characterization 
Based on the simulation results, a set of tube lenses was characterized to assess their 
performance. Tube lenses 5 mm in length with diameters of 3, 4, 5, and 6 mm were tested. 
Histidine was infused into the mass spectrometer at 100 µM as the test analyte. The pressure in 
the mass analyzer chamber was 1 Torr with ambient air as the buffer gas. The RF applied to the 
CIT was 14.4 MHz, and a small axial potential was applied to the endcap nearest the inlet at 
4.8 MHz and 5 Vp-p. A voltage of +130 V was applied to the capillary and the tube lenses were 
pulsed from +230 V during ion injection to GND during other parts of the scan.  
The results from each of the tube lenses tested are shown in Figure 3.3. Figure 3.3a shows 
a sample histidine mass spectra for each of the tube lenses. The protonated molecule is clearly 
visible in each spectrum at m/z 156, along with a fragment at m/z 110 (loss of carboxylic acid). 
Although ESI is a relatively soft ionization technique, it is not surprising to see some 
fragmentation under HPMS conditions. The high pressure (1 Torr) results in more collisions of 
analyte molecules with buffer gas, which can lead to the conversion of kinetic energy to internal 
energy and cause fragmentation. As the tube lens diameter is increased, there is a clear increase 
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in signal for both peaks in the spectrum. Figure 3.3b shows the signal-to-noise ratio (S/N) for the 
protonated molecule in each of the spectra. While each tube lens generates spectra with high 
enough S/N for quantitation, there is a clear advantage of the 6 mm ID lens over the other three. 
The S/N is roughly double that of the 4 and 5 mm lenses, and almost five times that of the 3 mm 
lenses. An ID of 6 mm is the practical upper limit due to space constraints in the high pressure 
mass spectrometer, so larger ID lenses were not tested. With the clear advantage of the 6 mm ID 
lens over the others for histidine, a 6 mm ID lens was used for all further analysis of amino acids 
by HPMS. 
3.3.3 Amino Acid Standards 
After optimization of the tube lens ID, several other changes were made for the analysis of 
amino acids compared to initial efforts presented in Chapter 2. First, according to Equation 3.1, 
the resolution can be improved by increasing the drive frequency applied to the ring electrode. In 
order to improve the resolution under HPMS conditions, the drive frequency was increased to 
close to 30 MHz from less than 10 MHz implemented previously. In order to implement HPMS 
at 30 MHz, according to Equation 3.2, the trap size must be decreased to maintain practical 
voltages. In this case, the trap size was decreased from critical dimensions around 280 µm to 
100 µm. With the decrease in trap size comes a decrease in trapping capacity, so a SLIT 
geometry was used instead of a CIT to increase the number of ions that can be trapped and 
improve sensitivity. Finally, an aperture inlet was found to have similar ion transmission and 
flow rates to a capillary but was simpler to implement in the mechanical design, so an aperture 
inlet was used for amino acid analysis.  
 Each of the 20 common amino acids was infused separately into the mass spectrometer at 
a concentration of 50 µM. The spectra for each amino acid are shown in Figure 3.4, in order of 
 88 
increasing mass from bottom to top. The RF frequency applied to the ring electrode was 
30.6 MHz, and axial RF was applied to the endcap at 7.67 MHz and 4.0 Vp-p. A 50 µm ID 
aperture was used, +35 V was applied constantly to the inlet. The 6-mm ID tube lens had +20 V 
applied during ion accumulation and -50 V during all other parts of mass analysis. Each 
spectrum is an average of 1000 individual mass scans. The mass range was the same as previous 
analyses, approximately 70 to 220 m/z. The protonated molecule ((M+H)+) for each compound is 
easily detectable, which should provide enough information for compound identification in many 
scenarios, especially those that are targeted. The aberrations in the baselines of glycine and 
alanine are artifacts from filtering and show the lower S/N of those molecules. They were 
detected at lower S/N likely because of their small size and can be scattered more easily than 
amino acids of larger mass by collisions with the buffer gas. Most spectra only contain the 
protonated molecule, but the aspartic acid and cysteine spectra have additional features. These 
features are probably adducts of the analytes with solvent molecules. Even with these adducts 
and other features, a peak for the protonated molecule is easily detectable.  
 Significant improvements for these spectra were observed over the infusions performed 
during the initial development of the platform discussed in Chapter 2. Comparisons of two 
sample spectra of proline and arginine are shown in Figure 3.5a and b, respectively. For proline 
(Figure 3.5a), the same features are observed in each spectrum, including a prominent (M+H)+ 
peak and some other minor peaks at higher m/z. However, the new spectrum (top, red) shows 
several improvements over the previous spectrum (bottom, black) including in S/N and reduced 
peak width (full-width half maximum, FWHM). The S/N increased from 14.5 to 407.9, and the 
FWHM was narrowed from 7.1 to 3.4 m/z. Similar improvements are seen with the arginine 
spectra in Figure 3.5b. The largest peak in each arginine spectrum is the protonated molecule, 
 89 
and some smaller features are observed at lower m/z. As with the proline spectrum, there are 
significant enhancements in S/N and FWHM in the new arginine spectrum over the previous 
spectrum. The S/N increased from 50.1 to 618.5, and the FWHM narrowed from 9.6 to 3.2 m/z. 
A complete list of improvements in S/N and FWHM for each of the amino acids over previous 
analyses is shown in Table 3.1. There was an average of 28-fold increase in S/N, and the FWHM 
narrowed 2.6-fold on average.  
 With detectability of each amino acid shown, a separation of a mixture of the twenty 
common amino acids was performed to demonstrate the viability of a CE-ESI-HPMS platform 
for small molecule analysis. The results of the separation and detection are shown in Figure 3.6. 
The same RF frequencies and voltages, DC voltages, and pressure (1 Torr) as the amino acid 
infusions were used. A 10-cm CE-ESI device was used with a separation channel field strength 
of about 1000 V/cm. Hydrodynamic injections were performed for 5 s each. A BPI 
electropherogram from the analysis is shown in Figure 3.6a with amino acid labels for each peak. 
The separation is performed in under 1.8 min, and 18 of the 20 common amino acids are 
detected, with the two smallest amino acids, glycine and alanine, going undetected. Species that 
might overlap in an HPMS spectrum are separated in the CE dimension. For example, leucine 
(L) and isoleucine (I) have exactly the same mass and are completely separated with microchip 
CE. There are some components that are unresolved in the CE domain, namely the co-migrating 
pairs methionine (M) and threonine (T), asparagine (N) and proline (P), tryptophan (W) and 
glutamine (Q), and glutamic acid (E) and cysteine (C). However, each of these pairs is easily 
distinguished in the mass spectral domain. This is readily seen in the 2D plot showing the 
migration times and m/z in Figure 3.6b. In this case, each of the spots corresponds to an amino 
acid, and it is easy to see where each amino acid is detected and separated. For example, 
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glutamine (Q) and tryptophan (W) co-migrate in the CE domain, but their protonated molecules 
(147 and 206 m/z, respectively) are clearly resolved in the mass domain. Even though some 
resolution is lost due to the operation at HPMS conditions, coupling with a CE separation makes 
up for some of that loss and enhances the potential for compound separation and identification. 
3.3.4 Amino Acid Consumption and Cell Growth  
In order to simulate consumption of amino acids from growth medium in a bioreactor, 
bacterial cells were grown in LB medium in flasks. The workflow for the experiment is shown in 
Figure 3.7. Cells were incubated in LB (Step 1), then samples of growth medium were taken and 
centrifuged to eliminate cell debris. The supernatant was then filtered with a 0.22 µm syringe 
filter (Step 2). Samples were then diluted 100X in BGE (49% methanol, 2% formic acid) and 
spiked with valine-d8 as an internal standard (Step 3). Finally, each of the samples were loaded 
onto a 10-cm CE-ESI device for analysis by CE-HPMS (Step 4). The field strength for the 
separations was about 1000 V/cm, and hydrodynamic injections were performed for between 30 
and 40 s. The pressure in the mass spectrometer was 1 Torr with ambient air as the buffer gas, 
and all other mass spectral parameters were the same as listed in the previous section for the 
infusions of amino acids. 
    To determine the components in growth medium to monitor, samples of growth medium 
before and after cell growth were analyzed. Figure 3.8 shows electropherograms of the growth 
medium before any cell growth and after 24 hours of cell growth. The numbered peaks indicate 
the same components in each electropherogram: arginine (1), isoleucine (2), and phenylalanine 
(3); the migration times were slightly different due to slight differences in electric field strength. 
The peaks marked with an asterisk indicate amino acids that were consumed over this time 
period. Those peaks correspond to serine, proline and asparagine (same peak), and tryptophan.  
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Some other components were consumed over this time period, but these amino acids were 
chosen as the primary targets for this analysis. Many of the other components, including other 
amino acids, remained unchanged over this time period of cell growth.  
After determining which amino acids were consumed, another batch of cells were grown, 
and samples of the growth medium were acquired every 30 min for 9 h and one time point at 
24 hours. Sample electropherograms from 0 h, 5.5 h, and 24 h are shown in Figure 3.9. The 
migration times were adjusted to align with the 0 hour time point for easy visualization of the 
changes between them. The peaks with asterisks indicate compounds that are completely 
consumed over this time period. The peak corresponding to isoleucine was overloaded 
intentionally to monitor other amino acids at lower concentrations. Based on the data in Figure 
3.8, isoleucine was not expected to be consumed over this time period. Some amino acids are 
consumed at different rates than others, and some only partially consumed. Arginine, for 
example, is only partially consumed over the 24 hour time period. Figure 3.10 shows mass 
spectra of arginine at the three time points shown in Figure 3.9. The primary peak, the protonated 
molecule at m/z 175, drops in intensity over this time period, and the other smaller peaks in the 
spectrum decline in intensity as well. 
In order to quantify the consumption of the targeted amino acids, their peak intensities 
were compared with that of the internal standard, valine-d8. Their intensities at different time 
points relative to the internal standard and normalized to the time zero point are shown in Figure 
3.11, along with the cell growth curve, as measured by the OD600. Cell growth enters the 
exponential phase around 2 hours of cell growth, and begins to level off around after 6 hours of 
growth. As the cells grow, the amino acids are consumed at different rates with some not 
consumed at all. Valine, as shown in Figure 3.11, is an example of a component that is not 
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consumed in the 24 h time period. Serine, proline, and tryptophan were all completely consumed 
over this time period, albeit at different rates. Serine was consumed at the fastest rate, followed 
by tryptophan, and finally proline. Utilization of certain amino acids and their consumption at 
different rates could indicate factors affecting cell growth. For example, a lack of serine has been 
shown to induce stress and inhibit cell growth in certain types of cancer cells.32  
The ability to track the components in growth medium in such a short time presents an 
opportunity for real-time monitoring of cell growth. Using the microchip CE platform, the amino 
acids in LB growth medium can be separated in under 3 minutes, and HPMS detection offers a 
simple and less expensive alternative to conventional mass spectrometry methods. Thus, there is 
potential for a CE-HPMS platform to be used as an on-line monitoring and screening tool to 
inform cell growth for biopharmaceutical or other applications. For example, if the concentration 
of serine is known at all times and is necessary for cell growth, the concentration can be adjusted 
in real-time to ensure the proper development of cells.   
3.3.5 CE-HPMS of Opiate Standards 
Opiate standards were dissolved in BGE at 5 µg/mL each. They were separated on a 23-cm 
microchip CE device before ESI into the mass spectrometer. Electrokinetic injections of 0.2 s 
were performed, and the field strength was about 675 V/cm. For HPMS detection, the pressure 
was 1 Torr with ambient air as the buffer gas, and the trap was operated with a drive RF of 
8.1 MHz and no axial RF. The capillary was operated at +75 V, and the gate lens was pulsed 
from +30 V during ion injection to GND. The separation and detection of a mix of 13 standards 
with HPMS detection (red, bottom) and a commercial mass spectrometer (Synapt G2, black, top) 
is shown in Figure 3.12. All 13 components are detected with the Synapt G2, and 11 of the 13 
components were detected with the HPMS system. The opiates were detected with similar 
 93 
efficiencies and S/N in each electropherogram. The two components that were undetected with 
HPMS were methadone and cis-tramadol. Because of the high pressure of the HPMS system, it 
is likely that methadone and cis-tramadol are fragmenting in the mass spectrometer, and the 
subsequent fragments are outside the current mass range and therefore undetected. There are also 
different intensity ratios of the drug standard peaks. The most intense peak in the HPMS 
electropherogram corresponds to buprenorphine, while the most intense peak in the Synapt G2 
electropherogram corresponds to three co-migrating compounds: hydromorphone, codeine, and 
methadone. As this particular method is targeting identification and not quantitation, differences 
in intensity are not important, but an internal standard could be used if quantitation was 
necessary in the future. 
The separation and detection of the opiate standards with HPMS is shown in the 2D plot in 
Figure 3.13 to view both CE and mass spectral data, and to highlight the importance of each 
technique. Each spot on the 2D plot corresponds to a compound or one of its fragments. In this 
case, fragmentation was minimal. Three spots are labeled to highlight the advantage of both 
electrophoretic and mass spectral information. First, codeine and hydrocodone are labeled and 
have the same mass, but are separated in the CE domain. Without the CE separations, these two 
components could not be distinguished by HPMS. Second, hydromorphone and codeine 
co-migrate, but have distinct masses. Without HPMS, hydromorphone and codeine could not be 
distinguished. There are several other compounds in the mixture that would overlap in either 
domain, demonstrating the need for both steps for an effective analytical platform. 
3.3.6 CE-HPMS of Codeine in Urine Samples 
To demonstrate the viability of CE-HPMS for the analysis of opiates in complex matrices, 
codeine was spiked into urine at varying concentrations. The workflow for the experiment is 
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shown in Figure 3.14. Codeine was spiked into 1 mL urine samples (Step 1). The urine samples 
were then loaded onto a solid phase extraction (SPE) column (Waters HLB, Step 2). The samples 
were then eluted off the column with 100 µL of BGE, giving a 10x concentration factor (Step 3) 
before analysis by CE-HPMS (Step 4). Microfluidic platforms offer the integration of many 
elements onto one device, so it is possible that an SPE bed could be incorporated onto the 
microchip in the future. However, for this proof-of-concept experiment, all SPE was performed 
off-line. A CE device with a 10-cm separation channel was used, and the field strength was about 
1000 V/cm. Injections were performed hydrodynamically for 5 s each. The mass spectrometer 
was operated at 1 Torr pressure with ambient air as the buffer gas, and all other mass spectral 
parameters were the same as described above for the analysis of the opiate standards.  
Two sample electropherograms are shown in Figure 3.15. The bottom trace (black) shows 
a blank urine sample, and the top trace shows a sample spiked with codeine at a concentration of 
100 ng/mL. The separation is performed in less than 2.1 min. Urine is a complex matrix, and the 
blank trace contains many peaks corresponding to various metabolites and other compounds in 
urine. When codeine is spiked in the sample at 100 ng/mL, there is a clear peak that appears in 
the electropherogram corresponding to codeine, labeled in the figure. Codeine can be identified 
as a spot in a 2D plot as well. Figure 3.16 shows 2D plots of codeine spiked into urine at two 
concentrations: 100 ng/mL (Figure 3.16a) and 10 ng/mL (Figure 3.16b). The spots corresponding 
to codeine are labeled in the figure. In both cases, codeine is separated from components of 
similar mass in the CE domain. Likewise, at the lower concentration in Figure 3.16b, codeine 
would not be distinguishable from other co-migrating components, further demonstrating the 
power of performing a separation step with HPMS detection. According to information from the 
Mayo Clinic, the necessary limit of quantitation (LOQ) to determine exposure for most opiates is 
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25 ng/mL.33 The detection of codeine in urine at 10 ng/mL is within that LOQ, indicating that 
CE-HPMS could be viable alternative to LC/MS or GC/MS methods to detect opiates in urine. 
 
3.4 Conclusion 
Improvements and applications for ESI-HPMS analysis of small molecules have been 
demonstrated. SIMION simulations were used to guide the development of DC ion optics in the 
form of a tube lens to increase ion transmission over the initial design. The platform was used for 
the analysis of amino acid standards at 50 µM, and significant improvements were shown in both 
S/N and peak width. Amino acid content in LB growth medium was monitored and correlated 
with cell growth, demonstrating the viability of CE-HPMS for real-time measurements of 
bioreactor content. Finally, opiate drug standards were detected and compared with a commercial 
mass spectrometer. After SPE, codeine was detected in a urine sample as low as 10 ng/mL, 
showing a possible small molecule target for forensic application of CE-HPMS.  
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3.5 Figures and Tables 
 
Figure 3.1: Instrument diagram (CAD) in A) isometric and B) cross-section view. Similar to the 
previous instrument design, there are two vacuum chambers, one for mass analysis at >1 Torr, 
and one for detection at <50 mTorr. The trap resides in the mass analysis chamber and acts as the 
conductance limit between the chambers. 
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Figure 3.2: Results of SIMION simulations. A) Potential energy surface with capillary and gate 
lens. B) Ion trajectories using voltages applied to the capillary and gate lens without gas flow. C) 
Ion trajectories with 300 m/s gas flow in the y-direction (toward the trap). D) Potential energy 
surface with capillary and tube lens. E) Ion trajectories using voltages applied to the capillary 
and tube lens without gas flow.  
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Figure 3.3: Effects of tube lens ID on mass spectra with A) Sample mass spectra of histidine and 
B) S/N of histidine protonated molecule at various tube lens IDs. 
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Figure 3.4: Infusion-ESI-HPMS spectra of each of the twenty common amino acids at 50 µM. 
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Figure 3.5: Sample amino acid mass spectra taken with a tube lens (red, top) compared to a gate 
lens (spectra from Chapter 2; black, bottom) of A) proline and B) arginine. 
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Table 3.1: HPMS improvements in S/N and FWHM for the 20 common amino acids before and 
after system optimization. 
Amino Acid S/N Before S/N After  FWHM Before FWHM After 
Ala 6.9 7.9  7.4 4.1 
Arg 50.1 618.5  9.6 3.2 
Asn 18.8 525.2  8.6 3.4 
Asp 48.1 435.3  12.0 3.8 
Cys 7.3 345.3  14.8 5.2 
Gln 17.7 978.3  11.4 3.2 
Glu 42.4 500.4  8.5 3.2 
Gly 6.5 7.6  7.9 4.0 
His 36.1 1008.2  9.1 2.6 
Ile 11.3 820.2  9.7 3.8 
Leu 21.2 679.5  10.8 3.8 
Lys 59.6 843.3  7.6 3.0 
Met 100.0 1756.2  8.5 3.0 
Phe 42.1 986.2  8.6 4.4 
Pro 14.5 407.9  7.1 3.4 
Ser 9.7 649.2  7.1 3.8 
Thr 23.1 318.2  11.5 3.8 
Trp 17.8 1030.1  10.8 4.6 
Tyr 87.5 101.4  9.9 4.1 
Val 18.1 665.7  9.8 4.2 
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Figure 3.6: CE-HPMS separation and detection of amino acid standards in A) a standard 
electropherogram and B) a 2D plot showing both migration time and m/z.  
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Figure 3.7: Workflow for growth medium sample experiments. 1) E. coli are incubated at 37 °C 
in LB growth medium. 2) Samples are centrifuged and subsequently filtered with 0.22 µm 
syringe filter. 3) Samples are then diluted 100X in BGE and an internal standard added and 4) 
analyzed by CE-HPMS. 
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Figure 3.8: CE-HPMS electropherograms pre (black, bottom) and post (red, top) cell growth. 
The numbered peaks correspond to the same components, and the starred peaks are amino acids 
that are consumed over this time period.  
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Figure 3.9: Sample electropherogram time points over the course of cell growth. The migration 
times were adjusted to correspond with the 0 h time point for visualization. The starred peaks 
represent components that were consumed of the course of this experiment. 
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Figure 3.10: Sample arginine mass spectra over the time points shown in Figure 3.9.  
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Figure 3.11: Relative peak areas of four amino acids referenced to the internal standard shown 
with the cell growth as measured by OD600. 
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Figure 3.12: Electropherograms of opiate standards (5 µg/mL) detected on Synapt G2 (black, 
top) and HPMS (red, bottom). 1 – meperidine, 2 – hydrocodone, 3 – cis-tramadol* ,4 – 
hydromorphone, codeine, methadone*, 5 – oxycodone, 6 – morphine, 7 – oxymorphone, 8 – 
naloxone, fentanyl (0.5 µg/mL), 9 – naltrexone, 10 – buprenorphine. Starred components were 
not detected with HPMS. 
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Figure 3.13: 2D plot of CE-HPMS of opiate standards. Codeine, hydrocodone, and 
hydromorphone are labeled to highlight the need for both CE separation and MS detection. 
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Figure 3.14: Workflow for detection of codeine in urine. 1) 1 mL of urine is spiked with codeine. 
2) Spiked urine sample is loaded onto to Waters HLB SPE cartridge. 3) Sample is eluted from 
SPE cartridge in 100 µL of BGE. 4) Analysis by CE-HPMS. 
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Figure 3.15: Sample electropherograms of urine blank (black, bottom) and spiked with 
100 ng/mL codeine (red, top). 
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Figure 3.16: 2D plots of CE-HPMS of codeine spiked urine at A) 100 ng/mL and B) 10 ng/mL. 
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 Chapter 4: Investigation of ESI-HPMS for the Analysis of Proteins 
 
4.1 Introduction 
4.1.1 Background and Motivation 
The identification and structural determination of proteins has been incredibly important to 
life sciences research because the study of proteins gives “insights into the composition, 
structure, function, and control of the proteome, shedding light on complex biological processes 
and phenotypes.”1 In addition, proteins have increasingly been developed and characterized as 
therapeutic agents for various human diseases.2 In recent years, mass spectrometers have been 
the primary driving force in characterizing proteins both for scientific discovery and screening 
drug products. Initially, however, the primary applications of mass spectrometers focused on the 
analysis of small gas phase and volatile compounds because MS analysis requires charged, gas 
phase molecules. The advent of electrospray ionization (ESI)3,4 and matrix assisted laser 
desorption/ionization (MALDI)5,6 provided methods for the ionization and volatilization of large 
biomolecules and have driven much of the development of mass spectrometer technology. 
 Much like commercial MS development, the initial steps in the development of high 
pressure mass spectrometry (HPMS) focused on the study of gas phase and volatile analytes.7,8 
The previous chapters have shown that ESI and HPMS can be coupled efficiently, both with CE 
separations and direct infusions of analytes. However, the analytes have all been small molecules 
under about 1000 Da, and most of those below 400 Da. Expanding CE-HPMS analyses to 
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include proteins and species of much higher mass (10 kDa and higher) would greatly increase the 
number of potential applications for the miniature analytical platform.  
4.1.2 Mass Range Extension 
 The first step for HPMS analysis of proteins is extending the mass range. Previous ESI-
HPMS analyses only had a mass range from 70 to about 700 m/z. For most protein species of 
interest, the mass range will need to be extended to at least 2000 m/z, and higher for certain 
proteins. Equation 1.7, reproduced here as Equation 4.1, shows the relationship between m/z, 
voltage, frequency and trap size:9 
 (
m
z
)
max
= 
8Vmax
qmaxW
2(r02+2z02)
 4.1 
where z is the charge, m is the ion mass, Vmax is the maximum amplitude of the RF voltage, qmax 
is the trapping parameter and constant (usually 0.908), and r0 and z0 are the dimensional 
parameters of the trap. In order to extend the mass range, reducing or maintaining the RF 
frequency and reducing the trap size are options that can be explored. For illustration, the mass 
analyzer in Chapter 2 was operated at about 10 MHz with a trap size of r0 = 250 µm, which 
produced a maximum mass of about 220 m/z. If the frequency were cut in half to 5 MHz, and the 
trap size were reduced to r0 = 100 µm, with constant voltage, the result would be a roughly 25-
fold increase in the maximum mass, to around 5500 m/z. This strategy, reducing or maintaining a 
low frequency and reducing the size of the trap, is presented here to produce a mass range 
suitable for the analysis of intact proteins.  
4.1.3 Printed Circuit Board Ion Funnel 
 Another consideration for HPMS of proteins is the transfer of ions through vacuum to the 
mass analyzer. A DC tube lens was used for small molecules, but more complex optics such as 
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ion funnels have been shown to have near 100% transmission efficiency for protein-sized 
molecules.10 Ion funnels consist of a stack of concentric ring electrodes, narrowing in diameter to 
an exit orifice, and 180 degrees out-of-phase RF signals are applied to adjacent electrodes, which 
provides a restoring force to the center of the rings. A DC gradient is applied along the length of 
the funnel to drive ions toward the exit orifice in the axial dimension. Ion funnels are 
traditionally used in commercial mass spectrometers in the first vacuum stage (0.1 to 30 Torr), 
an ideal operational pressure range for HPMS. For HPMS operation, the ion funnel and the mass 
analyzer can be operated at the same pressure, and thus, in the same vacuum chamber, reducing 
instrument complexity. Traditional ion funnels can consist of as many as 100 electrodes,11 but a 
smaller, shorter design would fit better within the goal of a miniature analytical platform. Printed 
circuit board (PCB) technology has been used previously to produce ion funnels, which reduces 
the complexity of assembly and fabrication.12,13 Here, after first using SIMION simulations to 
optimize the funnel geometry, a small (20 electrodes) ion funnel is produced from PCB material 
to improve ion transport for HPMS applications.  
4.1.4 High m/z Applications of a CE-ESI-HPMS Platform   
The analysis of biotherapeutic drugs is one possible application for an HPMS system 
capable of measuring high m/z molecules. Biotherapeutics have grown as a treatment strategy in 
the past decades, especially monoclonal antibodies (mAbs), which have become a multibillion 
dollar industry.14 They are attractive candidates for many therapeutic applications because of 
their high specificity and low side effects.14,15 While mAbs have been extremely successful as 
drugs, it is important to characterize them prior to their administration in order to predict the 
effects they may have on human health and ensure the safety of patients. However, mAbs are 
often difficult to characterize due to their size (~150 kDa) and complexity.16 Much antibody 
 118 
characterization is performed using LC/MS methods,2 and recently, characterization of charge 
variants of intact mAbs and mAb drug conjugates were performed using microchip CE-MS.17,18 
The possibility of a high pressure mass spectrometry platform used for process characterization 
of biopharmaceuticals was discussed in Chapter 3. That HPMS system could be adapted for 
product (mAb) characterization and provide a targeted approach to screen for the proper 
production of protein therapeutics.  
Another possible application for measuring proteins by HPMS is monitoring glycated 
hemoglobin (HbA1c) in diabetic patients. As of 2015, diabetes affected 415 million people 
worldwide and is estimated to affect 642 million by 2040.19 HbA1c consists of a hemoglobin 
molecule to which a glucose group has been added nonenzymatically to one of the amino acid 
residues.20 While blood glucose has traditionally been used to monitor diabetes, blood glucose 
levels only give a snapshot of glycemic control and can vary greatly in the short term, which can 
lead to irreproducible measurement and misdiagnosis. HbA1c provides a way to measure longer 
term glycemic control, about 120 days, or the average lifetime of human erythrocytes.20–22 Many 
mass spectrometric methods have been developed to measure HbA1c,23–25 including a method 
from the Ramsey lab using microchip CE-MS.26 These methods all use conventional mass 
spectrometry instrumentation, which would limit them to use outside of clinical settings because 
of cost, size, complexity, and the need to be run by specialists. If a microchip CE-MS method 
could be adapted to run with HPMS rather than a commercial mass spectrometry, the simplicity 
and reduced cost of HPMS makes it a good potential candidate as a diagnostic tool in a clinical 
setting. 
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4.1.5 Summary 
HPMS is explored for the analysis of high mass and m/z species, specifically proteins. A 
PCB ion funnel is simulated, constructed, and characterized to improve ion transmission. Small 
and large proteins are investigated to demonstrate the viability of HPMS to measure these 
species. A proof-of-concept analysis of a mAb is demonstrated for applications in 
biopharmaceutical characterization. Finally, hemoglobin glycation is characterized using a 
microchip CE-HPMS method adapted from previous work26,27 to show the potential of the 
system as a diagnostic tool. 
 
4.2 Experimental 
4.2.1 Materials and Reagents 
HPLC grade acetonitrile, isopropanol, acetic acid (99.9%) and formic acid (99.9%) were 
obtained from Fisher Scientific (Fairlawn, NJ). Purified deionized water was obtained using a 
Nanopure Diamond water purifier (Barnstead International, Dubuque, IA). (3-Aminopropyl)di-
isopropylethoxysilane (APDIPES) was obtained from Gelest (Morrisville, PA). NHS-PEG450 
was obtained from NanoCS (Boston, MA). Myoglobin, cytochrome c, and bovine serum albumin 
were obtained from Sigma (St. Louis, MO). The mAb (IgG2) was supplied by Pfizer (St. Louis, 
MO). The background electrolyte (BGE) for all non-mAb protein infusion experiments was 50% 
acetonitrile, 49.9% water, and 0.1% formic acid (v/v/v, pH = 3.1). The BGE for the mAb 
infusion was 10% isopropanol, 89.8% water, and 0.2% acetic acid (v/v/v, pH = 3.2). 
Deidentified whole blood samples were obtained from McLendon Clinical Laboratories 
(Chapel Hill, NC). The samples were analyzed by McLendon for HbA1c levels using a Vitros 
5600 immunoassay (Ortho Clinical Diagnostics, Inc.). The fifteen samples had clinical HbA1c 
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values ranging from 5.0% to 13.0%. Samples were refrigerated at 4 °C prior to analysis. For 
analysis by CE-HPMS, 10 µL of whole blood (without any further processing) was added to 
990 µL of 50% acetonitrile, 47% water, and 3% acetic acid, for a 100X dilution. After that, 
100 µL of the 100X solution was added to 900 µL of the acetonitrile/water/acetic acid BGE, for 
a final dilution of 1000X. The 1000X sample was filtered using a Costar Spin-X 0.45 µm 
centrifugal filter prior to CE-HPMS analysis.  
4.2.2 Microchip Design and Operation 
Two microchip devices were used for this work: an infusion-ESI device and a CE-ESI 
device with a 23-cm separation channel. Device fabrication and coating details are outlined in 
Appendix I. Briefly, the devices were wet etched to a depth of 10 µm and full width of 70 µm. 
The devices were then coated with APDIPES via chemical vapor deposition. All of the 
APDIPES coated channels were then functionalized with 20 kDa PEG in order to suppress the 
EOF.  
 Devices were operated as described in Appendix II. All voltages were applied with 
platinum wire electrodes controlled by a custom LabVIEW program. Pressure to the devices was 
applied with 2 psi of air gated by 3-way valves from Clippard (Cincinnati, OH). For infusion 
devices, +5 kV was applied to one reservoir along with 2 psi pressure to facilitate electrospray. A 
voltage of +0.5 kV was applied to the other reservoir. For CE-ESI, injections were performed 
hydrodynamically. Voltages were turned off, and pressure was applied to the sample reservoir 
and a reservoir containing BGE for 3 seconds, then pressure was applied only to the reservoir 
containing BGE for 1 second. The voltages were then turned on, and normal zone electrophoresis 
began. Voltages were operated at +20 kV for the BGE reservoir and +1.2 kV for the pumping 
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reservoir. Pressure was provided to the pumping reservoir to provide the flow necessary for 
electrospray.  
4.2.3 Microchip ESI-HPMS 
Electrospray ionization-high pressure mass spectrometry (ESI-HPMS) experiments were 
performed with a custom atmospheric interface and differentially pumped vacuum system 
adapted from the system described in Chapter 3. A CAD drawing of the vacuum chamber and 
MS components is shown in Figure 4.1.  
 The microchip-ESI device (CE or infusion) was mounted on an adjustable x-y-z stage 
and positioned approximately 5-10 mm from the HPMS inlet aperture. A single-sided copper 
clad circuit board (M.G. Chemicals, Burlington, Ontario, Canada) was used to shield the ESI 
orifice on the chip form the voltages applied to the reservoirs (not shown). The corner of the 
microfluidic device extended about 5 mm through a slit in the board. The copper board was held 
at +0.5 kV for all experiments. 
 Ions were conducted into the vacuum chamber via a 100 µm ID aperture (Lenox Laser, 
Glen Arm, MD) mounted to the chamber and sealed with Viton o-rings (McMaster-Carr, Atlanta, 
GA). A potential of +265 V was typically applied to the inlet aperture. After traveling through 
the aperture, ions were conducted to the trap via a custom-built ion funnel made using printed 
circuit boards (PCBs). The PCB ion funnel consisted of 20 electrodes and 19 PCB spacers, each 
0.5 mm thick (Advanced Circuits, Inc., Aurora, CO). The electrodes were designed using 
EAGLE PCB circuit board design software (Cadsoft, Pembroke Pines, FL). The first and last 
electrodes of the funnel, along with two spacers, are shown in Figure 4.2a. The spacers contain 
copper traces to make electrical connection between the electrodes of the funnel. Surface mount 
capacitors (1 nF) and resistors (180 kW) were used for the ion funnel. Electrical connections 
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were made to the funnel via SMA feedthroughs mounted on the main vacuum chamber. The 
funnel was fixed to the mounting bulkhead (Figure 4.1) to which the CIT was also mounted via 
another custom circuit board (PCB mounting plate in Figure 4.1) shown in Figure 4.2b and c. 
The bottom (blue, c), top (red, b), and inner (green) layers of the board are shown, and the inner 
layer traces on the board act as vacuum feedthroughs to make electrical connection to the trap. 
The circuit board is sealed into vacuum with a face-sealed o-ring on either side of the board.  
 Miniature CIT electrodes were wet etched by Towne Technologies, Inc. (Somerville, NJ). 
Dimensions for the CITs were r0 = 100 µm, z0 = 125 µm, and endcaps with 165 µm hole 
diameters. Each ring electrode contained a single trap. Traps were assembled by manual 
alignment using alignment pins and holes etched in the electrodes. Electrodes were mounted to a 
custom plate with 55 µm teflon (PTFE) spacers between them. Drive RF waveforms were 
applied by a Rohde and Schwarz SMB 100A signal generator and amplified using a Mini 
Circuits TVA-R5-13 preamplifier and AR 305 power amplifier. The signal was resonated with a 
tank circuit, and applied frequencies ranged from about 5 to 10 MHz. A small supplementary RF 
voltage was applied to the endcap closest to the inlet using an AFG 3022B function generator 
(Tektronix, Beaverton, OR) to perform resonant or double resonant ejection. Custom LabVIEW 
software was designed to monitor, control, and collect data. A National Instruments PXIe-1073 
data acquisition chassis was used to interface the electronics and LabVIEW software.  
Ions were accumulated between 0.05 and 20 ms before analysis. They were then scanned 
out of the trap and detected with an electron multiplier (Detech 2300, Detector Technology, Inc., 
Sturbridge, MA) connected to a current preamplifier (SR570, Stanford Research Systems, 
Sunnyvale, CA). A typical mass spectrum was an average of 10 to 1000 individual mass scans. 
Two sets of pumps were used for differentially pumping the chamber. A dry scroll pump (SH-
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110, Agilent Technologies, Inc., Santa Clara, CA) was used on the mass analysis chamber 
(~1 Torr) and an Agilent TPS Bench turbomolecular pump (Model TV81M) backed by a dry 
scroll pump (SH-110) was used on the detector chamber (~10 mTorr). 
 
4.3 Results and Discussion 
4.3.1 SIMION Simulations of PCB Ion Funnel 
Ion simulations were performed prior to the design of the PCB ion funnel in order to guide 
its design. Ion trajectories were modeled with SIMION 8.1 software (Scientific Instrument 
Services, Inc. Ringoes, NJ). A hard-sphere collision model with SDS (statistical diffusion 
simulation) user program was used to predict the interaction of ions with background nitrogen 
gas. The funnel consisted of 20 cylindrical electrodes, each 0.5 mm in width, spaced by 0.5 mm. 
The first 10 electrodes had a diameter of 6 mm, and the next 9 decreased linearly to 2 mm in 
diameter. The last electrode had a diameter of 2 mm. A solid electrode was placed 2 mm from 
the exit of the funnel to mimic the location of the ion trap. RF and DC potentials were applied to 
the first 19 electrodes, and only a DC potential was applied to the last electrode. The solid 
electrode was maintained at GND.   
Simulations were performed with ions of 3 different masses and a range of charge states, in 
order to mimic protein and peptide molecules. The parameters used for the simulations are 
shown in Table 4.1. The only parameters adjusted between each of the masses were the collision 
cross-section and the charge states of the molecule. The DC potentials applied result in a gradient 
of about 67 V/cm between the first and last electrodes. Trajectories for ions of 1700 m/z with 
three different masses are shown in Figure 4.3 along with cross-sections of the electrodes: A) 
17000 Da with +10 charge, B) 8500 Da with +5 charge, and C) 1700 Da with +1 charge. An 
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isometric view with a few ion trajectories is shown in Figure 4.3d. For ions of 8500 and 1700 
Da, the trajectories are more disperse throughout the funnel than the 17000 Da ions, but there is 
still 100% transmission. The trajectories are also slightly more disperse at the exit of the funnel 
for the lower masses, but all of the ions are focused significantly more at the exit than at the 
entrance of the funnel, from a beam of 4 mm in diameter to a beam of less than 1 mm in 
diameter. 
Transmission efficiencies of 100% were observed for all three masses at 1700 m/z, but 
transmission could vary as a function of m/z. To test this, ion trajectories were simulated under 
the same conditions with ions of the same masses but varying the charge state. The ranges of 
charge states were chosen based on reasonable charge states for molecules of similar size. 
Charge states of +10 to +30 were tested for mass 17000 (1700 to 567 m/z), +5 to +20 for mass 
8500 (1700 to 432.5 m/z), and +1 to +5 for mass 1700 (1700 to 340 m/z). Transmission 
efficiency as a function of m/z is shown in Figure 4.4 for each of the different masses. 
Transmission efficiency was 100% for all charge states of the 17000 Da species, and for all m/z 
over 600. Ions of mass 8500 drop off in transmission efficiency at lower m/z (< 500), though 
transmission efficiency remained above 95%. Transmission efficiency dropped off more 
dramatically for ions of higher charge states for mass 1700. At 340 m/z, transmission efficiency 
was only about 25%. In the simulation, transmission loss was due to ions hitting the funnel 
electrodes. This was likely due to a combination of increased collisional scattering for ions of 
lower mass and the high effective potential experienced by ions of low mass and high charge. 
The effective potential experienced by an ion in an oscillating electric field is inversely 
proportional to the ions mass and directly proportional to its charge.12,28 All else being equal, 
ions of lower mass and higher charge will experience a greater effective potential. This could 
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result in better control of the ions, but near the exit of the funnel where the apertures narrow, this 
resulted in collisions with the electrodes inside the funnel.  Experimental parameters could be 
adjusted to increase efficiency for lower mass ions. For example, the RF frequency and voltage 
could be adjusted to improve ion focusing and the pressure could be decreased to reduce 
scattering from collisions. Since our initial target molecules are small proteins close to mass 
17000, the ion funnel was designed based on the simulation parameters. For the analysis of 
peptides or smaller molecules (<1700 Da), experimental parameters may need to be changed or 
new optics may need to be designed.    
The ion funnel was constructed from PCB materials with the fully assembled ion funnel 
shown in Figure 4.5 from a side view (A) and down the axis of the funnel (B). The funnel was 
about 2.5 cm in length, and the last electrode was about 2 mm from the entrance of the ion trap. 
The compact form factor of the funnel fits within the goal of a miniature analytical platform. The 
funnel was held together with metal screws and fixed to the mounting bulkhead shown in Figure 
4.1.  The PCB mounting plate from Figure 4.2 is also shown with the o-ring used for sealing and 
SMA connectors for electrical connection to the trap. This ion funnel was used for all ESI-HPMS 
protein experiments.  
4.3.2 HPMS Analysis of Small Proteins 
After the initial design, the experimental setup in Figure 4.1 and ion funnel in Figure 4.5 
were used for the analysis of small proteins. Infusions of 2.5 µM cytochrome c (MW ~12.3 kDa) 
and 2.5 µM myoglobin (MW ~17 kDa) were performed. The pressure was 1.5 Torr with ambient 
air as the buffer gas and the background gas for the ion funnel. The ion funnel was operated at 
1.12 MHz with a voltage of 90 Vp-p, with a DC gradient from +175 V to +50 V. The last 
electrode was held at +25 V during the ion injection period and pulsed to -50 V during mass 
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analysis to gate ions. The drive RF for the trap was 6.3 MHz, ramped from 70 to 270 Vp-p. The 
axial RF was applied continuously to the end cap nearest the inlet at 1.97 MHz and 1.5 Vp-p. 
Using Equation 4.1, the expected mass range under these conditions would be roughly from 
m/z 500 to 2000. 
HPMS spectra of the two proteins compared with spectra from a commercial mass 
spectrometer (Waters Synapt G2) are shown in Figure 4.6. In Figure 4.6a, the charge states of 
cytochrome c are clearly visible and a distribution similar to the commercial mass spectrum was 
observed. Peaks from m/z 600 up to 1400 are observed, corresponding to charge states +20 (~m/z 
615) down to +9 (~m/z 1367), with an average charge state of +16.4, calculated according to 
methods reported previously.29 The FWHM for the most abundant charge state was 13.4 m/z.  
Figure 4.6b shows the HPMS spectrum of myoglobin. The charge states observed agree 
with the charge states seen on the commercial mass spectrometer, with the exception of the peak 
at ~ m/z 618. That peak corresponds to the free heme group lost from myoglobin under our 
electrospray conditions. The heme group was not easily detectable by ESI-HPMS under these 
conditions. Nonetheless, peaks over the same mass range as cytochrome c are observed, 
corresponding to charge states +26 down to +12, with an average charge state of +20.6. The 
FWHM of the most abundant charge state was 14 m/z.  The HPMS charge state distribution 
looks slightly different than that of the Synapt G2. Rather than a steady decrease at m/z above the 
most abundant charge state (~m/z 740), there was an increase around m/z 1000. This behavior 
might be due to two distinct conformations of myoglobin that exist under these conditions. With 
two conformations, the mass of myoglobin remains unchanged, but the conformations may favor 
different amounts of charging, resulting in two distinct charge state distributions. Even with two 
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charge state distributions, the m/z values remain unchanged, so the mass of myoglobin could still 
be identified with mass spectral information presented.   
The spectra shown in Figure 4.6 demonstrate that HPMS can be performed on small 
proteins, extending the mass range of HPMS analysis to at least about m/z 1500, while previous 
HPMS work focused only on small molecules and did not exceed about m/z 200. Given the 
correlation with spectra from a commercial mass spectrometer, the HPMS spectra with the 
charge state distributions of the proteins could likely be used to identify them with a targeted 
approach. In addition, the spectra show that the PCB ion funnel works effectively for proteins of 
this size and can efficiently conduct ions into the trap for analysis. 
 The ion funnel improved ion transmission over previously used DC optics. Figure 4.7 
shows two HPMS myoglobin spectra run with the PCB ion funnel and with the DC tube lens 
used for small molecules in Chapter 3. All conditions were kept the same between the two 
spectra with only the ion optics changed. The spectrum with the ion funnel gives about an 8-fold 
increase in signal intensity over the spectrum with the DC tube lens. There are also more peaks 
corresponding to additional charge states of myoglobin visible in the ion funnel spectrum, 14, 
compared to 10 for the tube lens spectrum. Better sensitivity and more charge states should aid in 
the identification of protein species. Another interesting effect of the ion funnel spectrum is the 
center of the charge state distribution shifts to lower m/z compared to the tube lens spectrum. The 
trap is the same and operated under the same conditions, so this shift is likely due to differences 
in ion transmission of the ion optics for species of different m/z. 
   To more fully characterize the performance of the ion funnel and the trap, a limit of 
detection (LOD) experiment was performed with myoglobin as the analyte. Starting at 2.5 µM, 
serial dilutions of myoglobin in BGE were performed down to 1 nM, and the solutions were 
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infused into the mass spectrometer. The same conditions for the ion funnel and trap were used as 
the infusions of cytochrome c and myoglobin in Figure 4.6. As the concentration was decreased, 
the fill time for the ion trap was adjusted to maintain signal quality. At high concentrations, long 
fill times would result in overloading of the ion trap, leading to space charging effects and 
decreasing the quality of the mass spectra. At low concentrations, the fill time can be increased 
to attempt to maintain the total number of ions in the trap and maintain signal intensity. 
Techniques like automatic gain control can be implemented in conventional ion traps to adjust 
the fill time dynamically and maintain consistent signal across a wide range of concentrations. 
The ion fill time was adjusted in order to mimic this function and produce a practically viable 
LOD. As interfacing CE with HPMS is a goal of this project, the fill times of the trap were 
capped at 20 ms to maintain a reasonable duty cycle for detection of CE separations. 
 The LOD was calculated using the signal-to-noise ratio (S/N) from the most abundant 
charge states of myoglobin in each spectrum. The S/N was then normalized to 20 ms by 
multiplying the S/N at each concentration by 20 ms/[current fill time]. Fill times ranged from 
0.05 ms (the lower limit of fill times due to timing constraints in the LabVIEW software) up to 
20 ms, and are shown as a function of concentration in Table 4.2. A plot of the “adjusted S/N” as 
a function of concentration is shown in Figure 4.8. The adjusted S/N rolls off on the high end of 
the concentrations, indicating the end of the linear dynamic range. The low concentrations are 
more important for determining LOD and are also more practical for target analytes. An inset of 
the large graph shows the adjusted S/N plotted against concentration for 150 nM down to 1 nM. 
A linear fit of these points is shown on the graph with an R2 of 0.996, indicating good linearity 
over about two orders of magnitude concentration. Using an adjusted S/N of 3 as a cutoff, the 
LOD was determined to be 4.9 nM for myoglobin under these conditions.    
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4.3.3 HPMS Analysis of Large Proteins 
Extending the analysis of ESI-HPMS to include large proteins would greatly increase its 
possible areas of application. Myoglobin and cytochrome c are useful standards for 
characterizing mass spectral performance, but there are many proteins of interest of much greater 
mass (>50 kDa), including monoclonal antibodies (mAbs) used in the biotherapeutic industry. 
Bovine serum albumin (BSA) and a mAb were investigated with ESI-HPMS. 
BSA is a common protein standard of about 66 kDa, so it was chosen as an intermediate 
step to the analysis of mAbs, which have masses around 150 kDa. An infusion-ESI-HPMS 
spectrum of BSA is shown in Figure 4.9. The pressure of the ion funnel and the mass analyzer 
was 2.0 Torr with ambient air as the background gas. The ion funnel was operated at 1.072 MHz 
and 75 Vp-p, with a DC gradient from +175 V to +50 V. The last ion funnel electrode was pulsed 
from +30 V to -50 V to gate ions. The drive RF for the trap was 6.6 MHz, ramped from 100 to 
560 Vp-p. An axial RF voltage was applied constantly to the endcap closest to the funnel at 
2.05 MHz and 3.0 Vp-p.  
The mass range in Figure 4.9 was about 600 to 1800 m/z, slightly more than the mass range 
in Figure 4.6, due to the increased RF voltage applied to the trap ring electrode. Many charge 
states of BSA were observed over this mass range, with the maximum of the distribution around 
m/z 1125. The inset shows a deconvolution performed on the charge state distribution to predict 
the mass of the protein. The deconvolution was performed using a custom LabVIEW program 
and an algorithm based on the z-score algorithm developed by Zhang and Marshall.30 The 
deconvolution produces a peak with its center at 66.3 kDa, which agrees well with the accepted 
value of the mass of BSA at 66.4 kDa.31 The pressure had to be increased to 2 Torr in order to 
detect BSA when infused. While the increase in pressure could affect the ion transfer, it is more 
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likely that the increased pressure aids in trapping species of large mass. Ions of significant mass 
may be difficult to trap in the shallow potential well of the miniature ion traps, so the increase in 
pressure will result in more ion-neutral collisions and reduce the kinetic energy of the large 
molecules. With this increase in pressure, BSA was trapped and analyzed effectively, 
demonstrating that HPMS could be used to characterize proteins up to this size.  
To further investigate the possibility of high mass protein analysis, a mAb, specifically a 
g-immunoglobulin (IgG), was infused into the HPMS system. A normalized spectrum of the 
mAb is shown in Figure 4.10 compared with a spectrum acquired on a commercial mass 
spectrometer (Waters LCT Premier). In order to produce the desired mass range, the RF drive 
frequency on the trap was lowered to 5.1 MHz, and the voltage was ramped from 270 to 
800 Vp-p. The axial RF was operated at 1.8 MHz and 4 Vp-p. The pressure was increased to 
6.1 Torr with ambient air as the background gas, about three times higher than necessary with 
BSA. Just as the pressure was increased in order to trap BSA, the pressure needed to be 
increased further to accommodate the higher mass of the analyte (~150 kDa).  
The reduction in RF frequency and increase in voltage results in a mass range significantly 
higher than used for any previous HPMS analysis. The final mass range was about m/z 2500 to 
7000. There are three distinct charge state distribution observed in the HPMS spectrum of the 
mAb. The highest m/z distribution (~m/z 4500 – 5500) corresponds to the intact, fully folded 
antibody. The other two distributions at lower m/z (~3400 to 4400) likely correspond to a partial 
unfolding of the mAb. In an unfolded conformation, more sites on the protein are accessible for 
protonation by ESI, which results in greater charging and peaks at lower m/z corresponding to 
increased charge states. The set of charge state distributions seen is due to protein degradation of 
the sample over time. Nonetheless, the location of the peaks in the highest m/z charge state 
 131 
distribution agree well with the spectrum from the LCT Premier, confirming that these charge 
states correspond to the intact, fully folded protein. When a deconvolution was performed on the 
same set of peaks, the center of the deconvoluted peak was about 149 kDa (Figure 4.10 inset), 
which agrees with the expected mass of about 150 kDa. 
4.3.4 Analysis of Whole Blood Lysate by CE-HPMS 
Microfluidic CE-MS analysis of whole blood lysate was performed previously with a 
commercial mass spectrometer with a target application of diabetes diagnostics.26 A similar 
study was performed here with CE-HPMS. The small size and lower cost of a CE-HPMS system 
would make operation of the platform feasible in a clinical setting, where the cost, size, and/or 
complexity of a commercial mass spectrometer may not be a reasonable possibility. CE-ESI-
HPMS analysis was performed on blood samples in order to measure glycation of the b subunit 
of hemoglobin. 
For CE-HPMS analysis of whole blood, the mass spectrometer and ion funnel were 
operated at 1.5 Torr, with ambient air as the background gas. The trap was operated at 8.59 MHz, 
ramped from 110 to 520 Vp-p. A small axial potential of 2.65 MHz at 2.0 Vp-p was applied to the 
endcap nearest the ion optics. The RF frequency on the ion funnel was 1.12 MHz at 70 Vp-p. The 
DC voltages were +175 V on the entrance electrode, +50 V on the second to last electrode, and 
pulsed from +30 during ion injection to -50 V at all other times on the last electrode. 
Microfluidic CE separations of two blood samples are shown in Figure 4.11. The bottom 
trace shows a separation of whole blood lysate from a patient with normal levels of HbA1c, and 
the top trace shows a separation of the same sample spiked with about 10% more pure HbA1c. 
The separation is performed in under two minutes, and three peaks are detected in each sample, 
corresponding to the two major subunits of hemoglobin, a and b, and the glycated b subunit. The 
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same separations were performed on a commercial mass spectrometer to confirm the identities of 
the peaks. In the previous study with a commercial mass spectrometer, the glycated a subunit 
was also detected, but that variant was not detected with HPMS. Nonetheless, when the sample is 
spiked with HbA1c, there is a clear increase in the intensity of peak 3 in Figure 4.11. This peak 
corresponds the glycated b subunit and agrees with previous results, indicating that monitoring 
relative sizes of the hemoglobin subunit peaks could be used to track HbA1c. It is worth noting 
that there are a number of additional proteins present in blood that were not detected here. This 
method was optimized for hemoglobin analysis, so additional undetected species were either 
below the current detection limit or out of the set mass range for these experiments. 
HPMS mass spectra of the major subunits of hemoglobin are shown in Figure 4.12. Each 
subunit has a set of well-resolved charge states in the range from 600 to 1000 m/z. The center of 
the a subunit distribution is at slightly lower m/z than the b subunit distribution, which could be 
used to distinguish the subunits in addition to the migration time information given by the 
separation. In addition, the charge state peaks for the two subunits would have significant 
overlap but do have different locations. When a deconvolution is performed on each of the 
spectra, the center of the deconvoluted spectrum for the a subunit was around 15.1 kDa, and the 
center of the deconvoluted b subunit spectrum was about 15.8 kDa. While the same degree of 
precision is not obtained as a commercial mass spectrometer, the deconvoluted masses from the 
HPMS spectra agree with the expected masses for the a and b subunits based on their amino acid 
sequences: 15126.4 Da and 15867.2 Da, respectively.26,32 The mass spectral information plus the 
electrophoretic migration times provide multiple criteria for the identification of different 
chemical species. 
 133 
The CE-HPMS platform was assessed as a tool for measuring HbA1c levels by analyzing a 
set of fifteen clinical samples with HbA1c levels from 5.0 to 13.0%. Each of the samples were 
analyzed by the same method used for the separation in Figure 4.11. Sample electropherograms 
of three of the samples with HbA1c values of 5.0, 7.2, and 13.0% are shown in Figure 4.13. The 
separation of the hemoglobin subunits (two tallest peaks) and the glycated b subunit (labeled 
with arrows) is completed in under two minutes. As the quantity of HbA1c increases, the height 
of the glycated b peak increases as well. Some other small peaks are present in 
electropherograms with similar migration times to the hemoglobin subunits of interest. These 
peaks likely correspond to other variants of hemoglobin. In addition, a small peak around 
2.1 minutes is observed in the 7.2 and 13.0% separations. This peak is probably due to another 
protein in the blood.  
Glycation levels in each of the blood samples were calculated using the relative peak areas 
of the glycated b subunit and the non-glycated b subunit, according to Equation 4.2: 
 
 
Ratiogly-HPMS= 
Agly-Hb-β
Agly-Hb-β+AHb-β
 4.2 
 
Each of the peaks from the BPI electropherograms were fit to a Gaussian profile in Igor Pro 6.3 
in order to calculate the areas. The ratio calculated from Equation 4.2 is plotted against the 
clinical HbA1c values in Figure 4.14. A linear regression was performed on the data, and a line 
of best-fit is shown in the Figure. The slope of the line is 1.2 with an intercept of 2.1. The R2 
value for the fit was 0.75, indicating a slight trend. The points at lower HbA1c values appear to 
have less variance and a more predictable trend than the points at higher HbA1c values, with the 
exception of the point at about 5.5% HbA1c. Given that there is a weak correlation between the 
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experimental values and the clinical values, this platform could possibly be used as an initial 
screening tool for diabetes diagnostics, perhaps distinguishing between a “high” and “low” 
HbA1c state. Previous work using this assay with a commercial mass spectrometer achieved an 
R2 of 0.99,26 indicating that this is a viable strategy for determining HbA1c levels. Further 
development and a stronger correlation would be needed for CE-HPMS to be used as an absolute 
quantitative method for HbA1c detection. The main difficulty with this measurement is the 
limited dynamic range of the HPMS system. The concentrations of the hemoglobin subunits and 
their structural variants vary over several orders of magnitude, and the HPMS system could 
currently be optimized for only one end of the range. Improvements using SLIT traps to increase 
the ion storage capacity or implementing some gain control might aid in increasing the dynamic 
range of the instrument. As shown in Figure 4.8, the HPMS system can operated over several 
orders of magnitude in concentration, but the ion injection time was adjusted at each step. During 
each separation, the ion injection time remained constant. While improvements to the system can 
be made, the correlation indicates that CE-HPMS could be used as a useful clinical tool for 
diabetes diagnostics.    
 
4.4 Conclusions 
The viability of HPMS to measure proteins has been shown. SIMION simulations were 
used to guide the development of a small PCB ion funnel that was successfully used to improve 
the transmission of proteins over simple DC optics. Small proteins (~15 kDa) were infused and 
analyzed at 1.5 Torr with ambient air as the buffer gas. Large proteins, including a mAb 
(~150 kDa), were also infused and detected at pressures up to 6 Torr, showing the possibility of 
HPMS for the analysis of biotherapeutic agents. Finally, variants of hemoglobin were separated 
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and detected using CE-HPMS. Clinical blood samples were analyzed and HbA1c values were 
correlated with clinical measurements. With further development, a CE-HPMS platform could 
provide a low cost, targeted alternative to conventional mass spectrometry analysis of proteins.  
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4.5 Figures and Tables 
 
 
Figure 4.1: Instrument diagram (CAD) in A) isometric and B) cross-sectional view. The 
instrument consists of two chambers. The first chamber is operated at high pressure (>1 Torr) 
and contains the PCB ion funnel and the ion trap, and the second chamber is operated at lower 
pressure (<50 mTorr) and contains an electron multiplier detector. 
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Figure 4.2: PCB schematics of A) the first and last plates of the ion funnel and two spacers, B) 
the bottom and inner layer of the PCB mounting plate, and C) the top and inner layers of the 
PCB mounting plate. The first ion funnel electrode is 6 mm in diameter, and the last is 2 mm in 
diameter. The spacers are used to make electrical connection between the boards. The blue and 
red sections in B) and C) are ground planes, and the green traces act as feedthroughs to carry 
electrical signals from atmosphere into the vacuum chamber. The trap is mounted in the center 
and vacuum sealed around the large circle (white, striped) with an o-ring. 
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Table 4.1: Parameters Used for SIMION Simulations. 
Parameter Value 
RF Frequency 1.07 MHz 
RF Amplitude 35 V0-p 
DC High 175 V 
DC Low 50 V 
DC Extract 30 V 
DC Collect 0 V 
Pressure  1.5 Torr 
Temperature  298 K 
Ion Initial Kinetic Energy 265 eV 
Number of Ions 1000 
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Figure 4.3: SIMION simulations of ion funnel in cross-section view with ion trajectories for A) 
mass 17000 Da and +10 charge, B) mass 8500 Da and +5 charge, and C) mass 1700 Da with +1 
charge (all 1700 m/z) D) Isometric and cross-section view of ion funnel and trajectories with ions 
of 17000 Da and +10 charge. 
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Figure 4.4: Ion % transmission as a function of m/z from SIMION simulations with ions of three 
different masses. 
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Figure 4.5: Pictures of PCB ion funnel A) mounted to bulkhead with trap and PCB mounting 
plate and B) in axial view. The largest electrode is 6 mm in diameter, and the smallest is 2 mm in 
diameter. Surface mount resistors and capacitors are mounted to tabs on the PCBs. 
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Figure 4.6: ESI infusions of A) cytochrome c and B) myoglobin with HPMS and a commercial 
mass spectrometer (Synapt G2). 
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Figure 4.7: Ion focusing optics comparison for an infusion of myoglobin using the PCB ion 
funnel and DC optics (Tube Lens).  
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Table 4.2: Ion injection times used for different concentrations of myoglobin. 
Concentration (nM) Ion injection time (ms) 
2500 0.05 
1250 0.05 
625 0.05 
313 0.2 
156 0.2 
78 0.5 
39 1 
20 2 
10 5 
5 10 
1 20 
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Figure 4.8: Adjusted S/N plotted for different concentrations of myoglobin. The inset shows the 
lowest seven concentrations with a linear fit to determine the limit of the detection. 
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Figure 4.9: ESI-HPMS infusion spectrum of bovine serum albumin (BSA). A deconvoluted 
spectrum of BSA is shown in the inset. 
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Figure 4.10: ESI infusion spectra of an IgG2 with both HPMS and a commerical mass 
spectrometer (LCT Premier). A deconvolution of the lowest charge states (highest m/z) is shown 
in the inset. 
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Figure 4.11: Electropherograms from CE-HPMS runs of whole blood lysate with normal levels 
of HbA1c (bottom) and spiked with 10% HbA1c (top). 
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Figure 4.12: Sample HPMS spectra of the subunits of hemoglobin from a microchip CE 
separation.  
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Figure 4.13: Sample CE-HPMS electropherograms of clinical blood samples with varying 
concentrations of HbA1c. The peak corresponding to the glycated b subunit is shown with an 
arrow. 
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Figure 4.14: Correlation of glycated b subunit to unmodified b subunit from CE-HPMS with 
clinically measured HbA1c. 
  
  
 152 
4.6 REFERENCES 
(1)  Aebersold, R.; Mann, M. Nature 2016, 537 (7620), 347–355. 
(2)  Qu, M.; An, B.; Shen, S.; Zhang, M.; Shen, X.; Duan, X.; Balthasar, J. P.; Qu, J. Mass 
Spectrom. Rev. 2016. 
(3)  Fenn, J.; Mann, M.; Meng, C.; Wong, S.; Whitehouse, C. Science. 1989, 246 (4926). 
(4)  Whitehouse, C. M.; Dreyer, R. N.; Yamashita, M.; Fenn, J. B. Anal. Chem. 1985, 57 (3), 
675–679. 
(5)  Tanaka, K.; Waki, H.; Ido, Y.; Akita, S.; Yoshida, Y.; Yoshida, T.; Matsuo, T. Rapid 
Commun. Mass Spectrom. 1988, 2 (8), 151–153. 
(6)  Karas, M.; Hillenkamp, F. Anal. Chem. 1988, 60 (20), 2299–2301. 
(7)  Blakeman, K. H.; Wolfe, D. W.; Cavanaugh, C. A.; Ramsey, J. M. Anal. Chem. 2016, 88 
(10), 5378–5384. 
(8)  Blakeman, K. H.; Cavanaugh, C. A.; Gilliland, W. M.; Ramsey, J. M. Rapid Commun. 
Mass Spectrom. 2016, 31 (1), 27–32. 
(9)  R. E. March and J. F. J. Todd. Practical Aspects of Ion Trap Mass Spectrometry, Volume 
1; CRC Press, 1995. 
(10)  Schaffer, S. A.; Tang, K.; Anderson, G. A.; Prior, D. C.; Udseth, H. R.; Smith, R. D. 
Rapid Commun. Mass Spectrom. 1997, 11 (16), 1813–1817. 
(11)  Kim, T.; Tolmachev, A. V.; Harkewicz, R.; Prior, D. C.; Anderson, G.; Udseth, H. R.; 
Smith, R. D.; Bailey, T. H.; Rakov, S.; Futrell, J. H. Anal. Chem. 2000, 72 (10), 2247–
2255. 
(12)  Chen, T. C.; Webb, I. K.; Prost, S. A.; Harrer, M. B.; Norheim, R. V.; Tang, K.; Ibrahim, 
Y. M.; Smith, R. D. Anal. Chem. 2015, 87 (1), 716–722. 
(13)  Ibrahim, Y. M.; Baker, E. S.; Danielson, W. F.; Norheim, R. V.; Prior, D. C.; Anderson, 
G. A.; Belov, M. E.; Smith, R. D. Int. J. Mass Spectrom. 2015, 377, 655–662. 
(14)  Larrick, J. W. Immunotherapy 2012, 4 (3), 257–261. 
(15)  Zhang, H.; Cui, W.; Gross, M. L. FEBS Lett. 2014, 588 (2), 308–317. 
(16)  Liu, H.; Gaza-Bulseco, G.; Faldu, D.; Chumsae, C.; Sun, J. J. Pharm. Sci. 2008, 97 (7), 
2426–2447. 
(17)  Redman, E. A.; Batz, N. G.; Mellors, J. S.; Ramsey, J. M. Anal. Chem. 2015, 87 (4), 
2264–2272. 
 153 
(18)  Redman, E. A.; Mellors, J. S.; Starkey, J. A.; Ramsey, J. M. Anal. Chem. 2016, 88 (4), 
2220–2226. 
(19)  Diabetes: facts and figures | International Diabetes Federation http://www.idf.org/about-
diabetes/facts-figures (accessed Jan 20, 2017). 
(20)  Little, R. R.; Sacks, D. B. Curr. Opin. Endocrinol. Diabetes Obes. 2009, 16 (2), 113–118. 
(21)  Sacks, D. B. Diabetes Care 2011, 34 (2), 518–523. 
(22)  Goldstein, D. E.; Little, R. R.; Lorenz, R. A.; Malone, J. I.; Nathan, D.; Peterson, C. M.; 
Sacks, D. B. Tests of glycemia in diabetes. Diabetes Care, 2004, 27, 1761–1773. 
(23)  Rai, D. K.; Landin, B.; Alvelius, G.; Griffiths, W. J. Anal. Chem. 2002, 74 (9), 2097–
2102. 
(24)  Zhang, X.; Medzihradszky, K. F.; Cunningham, J.; Lee, P. D. .; Rognerud, C. L.; Ou, C.-
N.; Harmatz, P.; Witkowska, H. E. J. Chromatogr. B Biomed. Sci. Appl. 2001, 759 (1), 1–
15. 
(25)  Roberts, N. B.; Green, B. N.; Morris, M. Clin. Chem. 1997, 43 (5), 771–778. 
(26)  Redman, E. A.; Ramos-Payan, M.; Mellors, J. S.; Ramsey, J. M. Anal. Chem. 2016, 88 
(10), 5324–5330. 
(27)  Redman, E. A. Development of a Microfluidic Capillary Electrophoresis-Mass 
Spectrometry Platform for the Characterization of Biotherapeutic Proteins, University of 
North Carolina at Chapel Hill, 2016. 
(28)  Gerlich, D. Inhomogeneous RF Fields: A Versatile Tool for the Study of Processes with 
Slow Ions; John Wiley & Sons, Inc., 1992. 
(29)  Iavarone, A. T.; Williams, E. R. J. Am. Chem. Soc. 2003, 125 (8), 2319–2327. 
(30)  Zhang, Z.; Marshall, A. G. J. Am. Soc. Mass Spectrom. 1998, 9 (3), 225–233. 
(31)  Hirayama, K.; Akashi, S.; Furuya, M.; Fukuhara, K. Biochem. Biophys. Res. Commun. 
1990, 173 (2), 639–646. 
(32)  Nakanishi, T.; Miyazaki, A.; Kishikawa, M.; Yasuda, M.; Tokuchi, Y.; Kanada, Y.; 
Shimizu, A. J. Mass Spectrom. 1997, 32 (7), 773–778. 
 154 
 
 Chapter 5: Conclusions and Future Directions 
 
5.1 Conclusions 
The overall goal of this work was to couple microchip electrospray ionization (ESI) 
sources with high pressure mass spectrometry (HPMS), specifically microfluidic devices that 
perform capillary electrophoresis (CE) with integrated ESI emitters. Prior to this work, HPMS 
development focused primarily on small, volatile and gas-phase analytes for applications in 
chemical threat detection.1,2 HPMS research with these targets has produced a hand-portable 
mass spectrometer from 908 Devices, Inc. that has been used successfully in the field, weighing 
2 kg and having a battery life of about 4 hours.3,4 While HPMS is now a commercially available 
technology, the available suite of possible analytes is limited to those already in the gas phase 
and ionizable by glow discharge ionization. Using HPMS with ESI greatly expands its 
capabilities and applications to include nonvolatile and liquid analytes, especially those of 
biological relevance. Adding a small separations platform (microchip CE) to the front end of 
HPMS analysis greatly increases the selectivity of the instrument and is an opportunity to 
develop an inexpensive alternative to conventional liquid chromatography-MS analyses. The 
development of CE-ESI-HPMS described here progressed in three stages. First, the initial proof-
of-concept for ESI-HPMS was shown followed by improvements for the analysis of small 
molecules. Finally, the system was adapted to investigate intact proteins. 
 A capillary interface was implemented to first demonstrate the possibility of ESI-HPMS. 
A small “gate lens” was used to focus ions into the miniature ion trap and prevent ions from 
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entering the trap during mass analysis. Using this interface, infusions of the 20 common amino 
acids were detected at 1 Torr with ambient air as the buffer gas. Peptides were infused and 
detected with much better sensitivity than the amino acids, most likely due to the fact that 
peptides have larger mass than single amino acids and are less likely to be scattered by collisions 
with buffer gas. The first demonstration of CE-ESI-HPMS was performed with a set of peptide 
standards that were detected with comparable efficiency to a commercial mass spectrometer. 
MS/MS was demonstrated with proton-bound dimers of tryptophan, MS4 was shown with 
clusters of acetaminophen. MS/MS was also performed on a peptide, leucine enkephalin, but 
with limited conversion efficiency and sensitivity.  
After the initial ESI-HPMS experiments, HPMS performance was optimized for the 
analysis of small molecules. SIMION simulations were used to guide the implementation of a 
tube lens to increase ion transmission. The RF drive frequency was increased to 30 MHz to 
improve resolution. With these improvements, the S/N for amino acid samples increased 28-fold 
on average, and the peak width as measured by FWHM decreased 2.6-fold on average. CE 
separations of amino acid standards were performed, and 18 of the 20 common amino acids were 
detected with HPMS. Two potential applications to validate the CE-HPMS platform were 
explored. The first application was as a rapid method for process control monitoring in the area 
of biopharmaceuticals.  This work focused on tracking the amino acid content in LB growth 
medium over time with the growth of bacterial cells. It was determined that several amino acids 
(i.e. serine, tryptophan, proline) were consumed at different rates over the course of cell growth. 
The rapid separations and detection indicate that this platform may be a viable method for 
monitoring cell growth in bioreactors for biopharmaceutical or other applications. The second 
application was in forensic analysis for the detection of opiates in urine where a small system 
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could eliminate the need for “two-tiered” testing. Opiate standards were first tested and 
compared with a commercial mass spectrometer. Similar detection was observed, with only 2 of 
13 standards going undetected by HPMS. Codeine was spiked into urine at various 
concentrations, and, after sample preparation by solid phase extraction, codeine was detected as 
low as 10 ng/mL, well below the standard LOQ of 25 ng/mL necessary for forensic 
applications.5  
One of the primary advantages of ESI is the ability to ionize large, liquid-borne 
biomolecules and get them into the gas phase for MS analysis.6 HPMS was adapted for the 
analysis of proteins by optimizing the parameters of ion trap operation and improving ion optics. 
Small ion traps (r0 = 100 µm) and low frequencies compared to previous analysis (as low as 
5 MHz) were implemented to scale the mass range for protein charge state detection. SIMION 
simulations guided the development of a PCB ion funnel, which improved signal intensity 
approximately 8-fold over the DC tube lens for an infusion of myoglobin. Infusions of small 
proteins (cytochrome c and myoglobin) were demonstrated and compared with a commercial 
mass spectrometer with good agreement between charge states detected on the two instruments. 
The practical LOD for myoglobin was determined to be ~5 nM. The frequency was adjusted to 
extend the mass range even further, and the proteins BSA (~66 kDa) and an IgG2 mAb 
(~150 kDa) were detected with HPMS. To investigate the possibility of using CE-HPMS in a 
clinical setting, whole blood lysate was analyzed to monitor hemoglobin A1c (HbA1c) ratios for 
diabetes diagnostics. Whole blood spiked with HbA1c showed an increase in intensity for the 
peak corresponding to the glycated b subunit of hemoglobin. Clinical blood samples with known 
HbA1c values were then analyzed by CE-HPMS. Using the ratio of the glycated b subunit to the 
total b concentration, the results from the HPMS platform showed some correlation (R2 = 0.75) 
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with the known values from the clinical samples. The current assay could possibly be used as a 
screening tool, but improvements still need to be made for definitive clinical diagnosis.  
CE-HPMS has been shown to be a viable tool for the analysis of a wide range of analytes, 
from amino acids to intact proteins. Future improvements and development should make it a 
valuable tool for many targeted analyses and a rapid and inexpensive alternative to large LC-MS 
platforms.  
 
5.2 Future Directions 
The initial development of a microchip CE-ESI-HPMS platform has been demonstrated, 
but there are improvements that could be made to optimize the system’s performance. Increases 
in ion transmission would increase the sensitivity of the instrument. The dynamic range, mass 
accuracy, and resolution of the mass analyzer could all be improved. Finally, a pressure tolerant 
detector like a Faraday cup could be used in place of an electron multiplier, eliminating the need 
for a turbo pump and significantly reducing the size and cost of the instrument.  
Relatively simple ion optics were used for this work, and modifications could be 
implemented to improve ion transmission. For example, the PCB ion funnel worked well for 
species of higher mass (i.e. proteins), but did not perform well for the transmission of amino 
acids. Changes in the funnel geometry including ring size, spacing, and number of electrodes 
could be optimized for transmission of small species or alternately to improve transmission of 
larger species. Another possibility to improve ion transmission would be to perform ESI inside 
the vacuum chamber. The Smith group at PNNL has shown significant gains in ion transmission 
using sub-ambient pressure ESI in combination with an ion funnel.7,8 Moving the ESI into the 
vacuum chamber eliminates losses of ions incurred at the atmospheric interface. If this strategy is 
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implemented, there will likely need to be optimization of the microchip source to operate at these 
pressures, along with significant changes in instrument design.  
One parameter of the mass analyzer that could be improved is the dynamic range, 
especially for protein analysis, which are large and highly charged. CITs were used for most of 
the work here, but different geometries, like SLITs, have increased ion storage and would 
increase the dynamic range. Furthermore, arrays of SLITs could be used for even greater ion 
storage, but uniformity of the trapping elements will be critical for maintaining mass resolution. 
SLITs were only used for some of the work here because the fabrication of the electrodes at 
small scales (r0 » 100 µm) resulted in nonuniform geometries and resulted in poor mass spectral 
resolution. Other fabrication techniques and electrode materials, such as deep reactive ion 
etching (DRIE) of silicon, could be used to produce uniform electrode surfaces at these small 
scales and ion storage could be increased without loss in (and possibly improve) mass spectral 
performance.9  
The mass accuracy of the mass analyzer could also be improved. While some loss of 
resolution is incurred operating at high pressure, mass accuracy is critical for proper 
identification of chemical species. While not rigorously characterized here, the mass accuracy 
was about 1 ppth at 1000 m/z for the HPMS platform. With proper calibration and standards, the 
mass accuracy could likely be improved. Another possibility for increasing mass accuracy is 
improved RF electronics. Small variations in voltage could cause significant variation in 
determination of m/z. Even with proper calibration, a reproducible and linear drive RF voltage 
are important for maintaining mass accuracy. 
Greater resolution of the mass spectrometer for ESI applications would greatly increase the 
selectivity of the instrument. Previous work has shown unit mass resolution for p-xylene at 
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1 Torr pressures with the RF drive frequency operated at around 60 MHz.9 Higher RF 
frequencies could be implemented in ESI-HPMS to improve resolution, but smaller traps will be 
needed to maintain a reasonable mass range for electrosprayed species. As mentioned above, 
small trapping features are difficult to fabricate with our current strategies, so other fabrication 
strategies (DRIE) and electrode materials (silicon) will be necessary to produce traps at sub-
100 µm scales. Reducing the size of the trap for higher frequencies and improved resolution will 
result in lower charge capacity, so SLITs and arrays of traps will likely be necessary to maintain 
charge capacity and dynamic range of the mass spectrometer.  
Though not the goal of this work, a sensitive detection method is crucial for mass 
spectrometer performance. A pressure tolerant Faraday cup detector would eliminate the need for 
a turbo pump. A differential chamber setup with electron multiplier detection was used for this 
work because electron multipliers have high gain and bandwidth, making them excellent 
detectors for ESI-HPMS development. Current Faraday cup technology does not have the 
sensitivity of electron multipliers, so the implementation of a Faraday cup detector will depend 
on the ability of the mass spectrometer to accumulate more charges (i.e. SLITs, arrays) or 
improved Faraday cup technology.  
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 Appendix I: ESI Device Fabrication and Coating 
A1.1 Microfabrication Procedure 
Microchip devices were fabricated using photolithography and wet etching techniques. The 
substrates were 0.5 mm thick 5” x 5” B270 glass from Perkin Elmer (Waltham, MA) pre-made 
with a layer of chrome and AZ1518 photoresist. The devices were patterned using a mask made 
in-house from soda lime glass and exposed to UV light (365 nm) for 60 s. The resist was then 
developed in AZ 400K developer (Integrated Micro Materials, Argyle, TX) for 90 s. The chrome 
was removed from the patterned areas using Chrome Etchant 1020 (Transene Company, Inc. 
Danvers, MA), stirred for 3 min. Channels were then etched into the glass using diluted 10:1 
buffered oxide etchant (BOE). Channels were etched to a depth of approximately 10 µm and a 
width of 70 µm, measured using a KLA Tencor P15 surface profiler (KLA Tencor Corp., San 
Jose, CA). Both sides of the device were then coated with AZ1518 photoresist before powder 
blasting vias through the substrate to provide fluidic connection to the channels. The photoresist 
was then removed using acetone. The remaining chrome was etched away using the same 
chrome etchant used above. The etched substrate was dry bonded to a blank 5” x 5” substrate of 
the same material before fusion bonding overnight at 550 °C. Devices were then diced using a 
precision dicer (Disco Technologies, Santa Clara, CA). Dicing cuts were made at 90° and served 
both to separate the devices on the substrate and to form the ESI emitter at one corner of each 
device. The emitter corner was then polished on a lapping wheel using 3 µm cerium oxide 
abrasive lapping paper (Ultra Tec, Santa Ana, CA). Finally, 8 mm x 8 mm cloning cylinders 
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were used as reservoirs and fixed to the devices using chemically resistant Loctite E-120HP 
epoxy (Henkel Corporation, Germany).  
 
A1.2 Device Coating Procedure 
Coating of the devices is a two-stage process. First, an aminopropyl silane (APS) reagent is 
chemically bonded to the surface of the devices in a gas-phase reaction. Second, a polyethylene 
glycol (PEG) reagent in the liquid phase is chemically bonded to the APS coating. 
A1.2.1 Chemical Vapor Deposition of APS Coating 
All devices (CE and infusion) were coated with (3-Aminopropyl)di-
isopropylethoxysilane (APDIPES) via chemical vapor deposition (CVD), resulting in uniform 
coatings across the surface of the devices. A commercial LabKote CVD system (Yield 
Engineering Systems, Livermore, CA) was used to coat the devices. The chamber was under 
vacuum and held at 160 °C throughout the coating. A 0.1 mL aliquot of APDIPES was injected 
into the chamber and reacted with the glass surfaces for approximately 15 min before purging the 
chamber with nitrogen. For a full coating procedure, 3 injections of APDIPES were performed. 
A1.2.2 PEGylation of APS Coating 
Two microchip configurations of PEG coatings were used. In one configuration, only the 
pumping channel was coated with PEG, while in the other, all channels were coated with PEG. 
The reagent used was NHS-PEG450 from NanoCS (Boston, MA). The PEG reagent was 
dissolved in 10 mM phosphate buffer (pH 7.5) at a concentration of 10 mg/mL. To flow 
solutions through the device, the PEG reagent was loaded into the reservoirs and vacuum was 
applied at the corner with the ESI emitter. Before coating with PEG solution, devices were 
treated with a solution of 0.1% formic acid, then rinsed with phosphate buffer (without PEG). 
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Devices were then treated with the PEG reagent solution for 30 to 45 minutes, depending on the 
length of the separation channel. After coating with PEG, devices were rinsed with DI water for 
at least 10 minutes. An alternate “residue coating” method has also been implemented, in which 
the devices are baked in the CVD oven for one cycle (without reagent injection) immediately 
after PEG coating and before rinsing. The devices were then rinsed with DI water for at least 
10 minutes after baking in the oven.  
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 Appendix II: Microchip Device Operation 
A2.1 Instrument Hardware 
Voltages were applied via platinum wire electrodes soldered to high voltage wire. The 
power was supplied to the electrodes with a custom-built power supply using high voltage 
modules from UltraVolt (Ronkonkoma, NY). Pressure to the devices was applied via rubber 
tubing and controlled using 3-way valves from Clippard (Cincinnati, OH). Air or nitrogen was 
used to apply pressure and regulated at 2 psi for all analyses. Timing for the application of 
voltages and pressures was controlled using a custom LabVIEW program.  
 
A2.2 CE-ESI Device Injection and Operation 
A sample schematic of a CE-ESI device is shown in Figure A2.1a, reprinted here from 
Chapter 2. Two types of injections were performed: electrokinetic and hydrodynamic. 
A2.2.1 Electrokinetic Injections 
For electrokinetic injections, voltages are applied to all four reservoirs: sample (S), 
background electrolyte (BG), sample waste (SW), and pumping channel (EO). Sample is loaded 
into reservoir S with background electrolyte in each of the other reservoirs. To perform an 
injection, voltages are switched from a “run” configuration to an “inject” configuration, and then 
back to the “run” configuration. Sample voltages from Chapter 2 are shown in Table A2.1. 
During the “run” configuration, the electric field drives sample from S to SW without entering 
the separation channel while BGE from B enters the separation channel and effectively gates the 
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sample to SW. When switched to “inject,” the voltages applied to reservoirs SW and BG are 
balanced, and sample enters the separation channel. The voltages are switched back to “run” 
thereby defining the sample plug length in the separation channel and zone electrophoresis 
occurs.  
For operation of these devices, a differential surface coating provided the flow necessary 
for ESI. The separation channel had an APDIPES coating (positive surface charge at low pH), 
which produces a strong anodic electroosmotic flow (EOF).  The EO channel had PEG 
covalently bound to the APDIPES coating, suppressing the EOF. The difference in EOF at the 
junction of these two channels results in pressure driven flow towards the corner of the device, 
which, in combination with the voltage applied to the EO channel, results in electrospray. It is 
important to note that electrokinetic injections could be performed with other coating 
configurations, but all electrokinetic injections in this work were performed with this surface 
coating configuration.  
A2.2.2 Hydrodynamic Injections 
For hydrodynamic injections, pressure is applied to reservoirs S, BG, and EO at different 
intensities between injection and the separation “run”. Voltage in this case is only applied 
between S and EO to perform the electrophoretic separation in the “run” phase. The sample is 
loaded into reservoir BG with the other reservoirs containing BGE. During the “run” phase, 
voltages are applied to reservoirs S and EO, and pressure is applied to EO to provide the flow 
necessary for ESI. To perform an injection, the voltages are turned off to S and EO and pressure 
is applied to reservoirs BG (containing sample) and S. This drives the sample into the separation 
channel and to SW. The injection profile is shown in Table A2.2. After injection, a short “clear” 
step is performed where pressure is applied to S to load the sample plug completely into the 
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separation channel and prevent excess sample from being injected. The voltages and pressures 
are then switched back to “run” and zone electrophoresis occurs.  
For hydrodynamic injections, all channels in the devices are coated with PEG, suppressing 
the EOF. Because there is no differential EOF between the separation and EO channel, pressure 
is applied to the EO reservoir to provide the flow necessary for sustaining ESI.  
A2.3 Infusion Device Operation 
A sample schematic of an infusion device is shown in Figure A2.1b. For normal operation, 
sample is loaded in each reservoir with +5 kV applied to the EO reservoir and 0 kV (GND) 
applied to the S reservoir. If the channels are differentially coated with APIDES in the infusion 
channel and APDIPES+PEG in the EO channel, the difference in EOF at the junction of the 
channels provides the flow necessary for ESI. For some applications, head pressure (2 psi, air or 
N2) was applied to the EO reservoir to produce a more stable electrospray over time. 
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A2.4 Figures and Tables 
 
Figure A2.1: Schematics for capillary electrophoresis (A) and infusion (B) glass microfluidic 
devices. All channels were etched to a depth of 10 µm. Reservoirs are designated with circles 
and indicate sample (S), background electrolyte (BG), sample waste (SW), and electroosmotic 
pump (EO). The microchip in A consists of an injection cross, a 46-cm serpentine separation 
channel, and an electroosmotic pumping channel. The infusion device (B) consists of a 5.5-cm 
channel and an electroosmotic pumping channel, and both reservoirs are filled with the sample. 
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Table A2.1: Sample operational voltages for electrokinetic injections. 
 Vrun (kV) Vinj (kV) 
S -14 -14 
BG -14 -13 
SW -12 -13 
EO +6 +6 
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Table A2.2 Voltages and pressures used in hydrodynamic injection sequence. A “V” subscript 
indicates a voltage applied to the reservoir, and a “P” subscript indicates a pressure.  
 Run Inject Clear 
SV +20 0 0 
EOV +1.5 0 0 
EOP On Off Off 
SP Off On On 
BGP Off On Off 
 
